<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="/ProjectMundo/style/jats-html.xsl"?>
<!DOCTYPE response>
<article article-type="research-article" dtd-version="1.2" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    41467
   </journal-id>
   <journal-id journal-id-type="doi">
    10.1038/41467.2041-1723
   </journal-id>
   <journal-title-group>
    <journal-title>
     Nature Communications
    </journal-title>
    <abbrev-journal-title abbrev-type="publisher">
     Nat Commun
    </abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2041-1723
   </issn>
   <publisher>
    <publisher-name>
     Nature Publishing Group UK
    </publisher-name>
    <publisher-loc>
     London
    </publisher-loc>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">
    s41467-024-46116-y
   </article-id>
   <article-id pub-id-type="manuscript">
    46116
   </article-id>
   <article-id pub-id-type="doi">
    10.1038/s41467-024-46116-y
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Article
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /692/499
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /692/308/575
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /141
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /38/23
     </subject>
    </subj-group>
    <subj-group subj-group-type="NatureArticleTypeID">
     <subject>
      article
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">
     Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial
    </article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" corresp="yes" id="Au1">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-5702-1759
     </contrib-id>
     <name name-style="western">
      <surname>
       Ni Lochlainn
      </surname>
      <given-names>
       Mary
      </given-names>
     </name>
     <address>
      <email>
       mary.ni_lochlainn@kcl.ac.uk
      </email>
     </address>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="corresp" rid="IDs4146702446116y_cor1">
      a
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au2">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-6941-8160
     </contrib-id>
     <name name-style="western">
      <surname>
       Bowyer
      </surname>
      <given-names>
       Ruth C. E.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au3">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-3514-4528
     </contrib-id>
     <name name-style="western">
      <surname>
       Moll
      </surname>
      <given-names>
       Janne Marie
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff3">
      3
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au4">
     <name name-style="western">
      <surname>
       García
      </surname>
      <given-names>
       María Paz
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au5">
     <name name-style="western">
      <surname>
       Wadge
      </surname>
      <given-names>
       Samuel
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au6">
     <name name-style="western">
      <surname>
       Baleanu
      </surname>
      <given-names>
       Andrei-Florin
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au7">
     <name name-style="western">
      <surname>
       Nessa
      </surname>
      <given-names>
       Ayrun
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au8">
     <name name-style="western">
      <surname>
       Sheedy
      </surname>
      <given-names>
       Alyce
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au9">
     <name name-style="western">
      <surname>
       Akdag
      </surname>
      <given-names>
       Gulsah
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au10">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-9066-4614
     </contrib-id>
     <name name-style="western">
      <surname>
       Hart
      </surname>
      <given-names>
       Deborah
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au11">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0003-0925-4632
     </contrib-id>
     <name name-style="western">
      <surname>
       Raffaele
      </surname>
      <given-names>
       Giulia
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff4">
      4
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au12">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-7904-7933
     </contrib-id>
     <name name-style="western">
      <surname>
       Seed
      </surname>
      <given-names>
       Paul T.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff5">
      5
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au13">
     <name name-style="western">
      <surname>
       Murphy
      </surname>
      <given-names>
       Caroline
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff6">
      6
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au14">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-8203-0769
     </contrib-id>
     <name name-style="western">
      <surname>
       Harridge
      </surname>
      <given-names>
       Stephen D. R.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff7">
      7
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au15">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-6702-3704
     </contrib-id>
     <name name-style="western">
      <surname>
       Welch
      </surname>
      <given-names>
       Ailsa A.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff8">
      8
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au16">
     <name name-style="western">
      <surname>
       Greig
      </surname>
      <given-names>
       Carolyn
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff9">
      9
     </xref>
     <xref ref-type="aff" rid="Aff10">
      10
     </xref>
     <xref ref-type="aff" rid="Aff11">
      11
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au17">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-5414-2950
     </contrib-id>
     <name name-style="western">
      <surname>
       Whelan
      </surname>
      <given-names>
       Kevin
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff12">
      12
     </xref>
    </contrib>
    <contrib contrib-type="author" corresp="yes" id="Au18">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-4910-0489
     </contrib-id>
     <name name-style="western">
      <surname>
       Steves
      </surname>
      <given-names>
       Claire J.
      </given-names>
     </name>
     <address>
      <email>
       claire.j.steves@kcl.ac.uk
      </email>
     </address>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="corresp" rid="IDs4146702446116y_cor18">
      u
     </xref>
    </contrib>
    <aff id="Aff1">
     <label>
      1
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s College London
      </institution>
      <institution content-type="org-name">
       Department of Twin Research and Genetic Epidemiology
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      SE1 7EH
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff2">
     <label>
      2
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/035dkdb55
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.499548.d
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 5903 3632
      </institution-id>
      <institution content-type="org-name">
       The Alan Turing Institute
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      NW1 2DB
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff3">
     <label>
      3
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/00g934978
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.509919.d
      </institution-id>
      <institution content-type="org-name">
       Clinical Microbiomics
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Copenhagen
     </addr-line>
     <country country="DK">
      Denmark
     </country>
    </aff>
    <aff id="Aff4">
     <label>
      4
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       GKT School of Medical Education
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff5">
     <label>
      5
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       Unit for Medical Statistics/Department for Women and Children’s Health, School of Life Course and Population Sciences, Faculty of Life Sciences and Medicine
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff6">
     <label>
      6
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s Clinical Trials Unit, Research Management and Innovation Directorate
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff7">
     <label>
      7
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       Centre for Human &amp; Applied Physiological Sciences
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff8">
     <label>
      8
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/026k5mg93
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8273.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 1092 7967
      </institution-id>
      <institution content-type="org-division">
       Department of Epidemiology and Public Health, Norwich Medical School
      </institution>
      <institution content-type="org-name">
       University of East Anglia
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      NR4 7TJ
     </addr-line>
     <addr-line content-type="city">
      Norwich
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff9">
     <label>
      9
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/03angcq70
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.6572.6
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 1936 7486
      </institution-id>
      <institution content-type="org-division">
       School of Sport, Exercise, and Rehabilitation Sciences
      </institution>
      <institution content-type="org-name">
       University of Birmingham
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff10">
     <label>
      10
     </label>
     <institution-wrap>
      <institution content-type="org-name">
       MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff11">
     <label>
      11
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/014ja3n03
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.412563.7
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 0376 6589
      </institution-id>
      <institution content-type="org-division">
       NIHR Birmingham Biomedical Research Centre
      </institution>
      <institution content-type="org-name">
       University Hospitals Birmingham NHS Foundation Trust and University of Birmingham
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff12">
     <label>
      12
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s College London, Department of Nutritional Sciences
      </institution>
      <institution content-type="org-name">
       Franklin Wilkins Building
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      SE1 9NH
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
   </contrib-group>
   <author-notes>
    <corresp id="IDs4146702446116y_cor1">
     <label>
      a
     </label>
     <email>
      mary.ni_lochlainn@kcl.ac.uk
     </email>
    </corresp>
    <corresp id="IDs4146702446116y_cor18">
     <label>
      u
     </label>
     <email>
      claire.j.steves@kcl.ac.uk
     </email>
    </corresp>
   </author-notes>
   <pub-date date-type="pub" publication-format="electronic">
    <day>
     29
    </day>
    <month>
     2
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <pub-date date-type="collection" publication-format="electronic">
    <month>
     12
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <volume>
    15
   </volume>
   <issue seq="1859">
    1
   </issue>
   <elocation-id>
    1859
   </elocation-id>
   <history>
    <date date-type="registration">
     <day>
      15
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="received">
     <day>
      4
     </day>
     <month>
      8
     </month>
     <year>
      2023
     </year>
    </date>
    <date date-type="accepted">
     <day>
      12
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="online">
     <day>
      29
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
   </history>
   <pub-history>
    <event event-type="Correction">
     <event-desc>
      A Correction to this paper has been published: https://doi.org/10.1038/s41467-025-58771-w
     </event-desc>
     <date>
      <day>
       10
      </day>
      <month>
       4
      </month>
      <year>
       2025
      </year>
     </date>
    </event>
   </pub-history>
   <permissions>
    <copyright-statement content-type="compact">
     © The Author(s) 2024
    </copyright-statement>
    <copyright-statement content-type="comment">
     corrected publication 2025
    </copyright-statement>
    <copyright-year>
     2024
    </copyright-year>
    <copyright-holder>
     The Author(s)
    </copyright-holder>
    <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
     <license-p>
      <bold>
       Open Access
      </bold>
      This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
      <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">
       http://creativecommons.org/licenses/by/4.0/
      </ext-link>
      .
     </license-p>
    </license>
   </permissions>
   <related-article ext-link-type="doi" related-article-type="correction-forward" xlink:href="10.1038/s41467-025-58771-w"/>
   <abstract id="Abs1" xml:lang="en">
    <title>
     Abstract
    </title>
    <p id="Par1">
     Mafunzo yanayotaka kusimamia mabadiliko ya gut microbiota yanaweza kubadilisha mawazo ya msimulizi wa misuli na usimamizi wa akili. Gut microbiota inaweza kuchukua kigeni katika upigani wa anabolic resistance ya misuli ya wazee, na usimamizi wa akili. Katika mafunzo yanayohifadhiwa kwa placebo na kuburudika mara mbili yanayohusika na 36 zawa (72 watu), wanaohitaji ≥60, kila zawa zinazohusiana zinaweza kupata placebo au prebiotic kila siku kwa muda wa 12 wiki. Msimulizi ya upigana na branched chain amino acid (BCAA) inapewa kwa wafanyikazi wote. Matokeo ni usimamizi wa misuli na akili. Mafunzo yanayotolewa kwa njia ya mbio kwa kutumia video visits, questionnaires ya mtandaoni na testing ya akili, na kutuma equipment na samples ya kibiologiki. Supplement ya prebiotic inaweza kupatikana na kusababisha mabadiliko ya gut microbiome [kwa mfano, upungufu wa relative
     <italic>
      Bifidobacterium
     </italic>
     abundance]. Hapana kubadilika kwa njia kubwa kati ya prebiotic na placebo kwa matokeo ya kwanza ya chair rise time (β = 0.579; 95% CI −1.080-2.239 p = 0.494). Prebiotic inasaidia usimamizi wa akili (factor score versus placebo (β = −0.482; 95% CI,−0.813, −0.141; p = 0.014)). Matokeo yetu yanatunza kuwa mazoezi ya gut microbiome yanaweza kusaidia usimamizi wa akili kwenye watu wazee. Tunatumia mifano ya mafunzo yanayotolewa kwa njia ya mbio kwa watu wazee, ambayo yanaweza kurekebisha kutokutofikana wa watu wazee katika mafunzo ya kliniki. ClinicalTrials.gov registration: NCT04309292.
    </p>
   </abstract>
   <abstract abstract-type="ShortSummary" id="Abs2" xml:lang="en">
    <p id="Par2">
     Here, the authors present the results of the PROMOTe trial, reporting improved cognition with prebiotic vs placebo in twins over 60 years old, probing that remote trials are feasible in older adults, and suggesting that the gut microbiota may represent a therapeutic target for age-associated morbidity.
    </p>
   </abstract>
   <kwd-group kwd-group-type="publisher-auto-generated" vocab="springer-nature-taxonomy" xml:lang="en">
    <kwd>
     Microbiome
    </kwd>
    <kwd>
     Nutritional Supplements
    </kwd>
    <kwd>
     Microbiota
    </kwd>
    <kwd>
     Cognitive ageing
    </kwd>
    <kwd>
     Placebo Effect
    </kwd>
    <kwd>
     Preclinical Research
    </kwd>
   </kwd-group>
   <kwd-group kwd-group-type="hierarchical" vocab="FoR" vocab-identifier="ANZSRC 2008">
    <kwd content-type="term" vocab-term-identifier="11">
     Medical and Health Sciences
    </kwd>
    <nested-kwd>
     <kwd content-type="term" vocab-term-identifier="1103">
      Clinical Sciences
     </kwd>
    </nested-kwd>
   </kwd-group>
   <funding-group>
    <award-group>
     <funding-source>
      <institution-wrap>
       <institution>
        DH | National Institute for Health Research (NIHR)
       </institution>
       <institution-id institution-id-type="doi" vocab="open-funder-registry">
        https://doi.org/10.13039/501100000272
       </institution-id>
      </institution-wrap>
     </funding-source>
     <award-id award-type="FundRef grant">
      NIHR300159
     </award-id>
     <principal-award-recipient>
      <name name-style="western">
       <surname>
        Ni Lochlainn
       </surname>
       <given-names>
        Mary
       </given-names>
      </name>
     </principal-award-recipient>
    </award-group>
   </funding-group>
   <custom-meta-group>
    <custom-meta>
     <meta-name>
      publisher-imprint-name
     </meta-name>
     <meta-value>
      Nature Portfolio
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-issue-count
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-article-count
     </meta-name>
     <meta-value>
      10926
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-pricelist-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-holder
     </meta-name>
     <meta-value>
      Springer Nature Limited
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-contains-esm
     </meta-name>
     <meta-value>
      Yes
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-month
     </meta-name>
     <meta-value>
      2
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-day
     </meta-name>
     <meta-value>
      15
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-product
     </meta-name>
     <meta-value>
      NonStandardArchiveJournal
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-grants-type
     </meta-name>
     <meta-value>
      OpenChoice
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      metadata-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      abstract-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodypdf-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodyhtml-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bibliography-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      esm-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      online-first
     </meta-name>
     <meta-value>
      false
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-file-reference
     </meta-name>
     <meta-value>
      BodyRef/PDF/41467_2024_Article_46116.pdf
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-type
     </meta-name>
     <meta-value>
      Typeset
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      target-type
     </meta-name>
     <meta-value>
      OnlinePDF
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-year
     </meta-name>
     <meta-value>
      2025
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-month
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-day
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-type
     </meta-name>
     <meta-value>
      OriginalPaper
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-primary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-collection
     </meta-name>
     <meta-value>
      Science (multidisciplinary)
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      open-access
     </meta-name>
     <meta-value>
      true
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      discipline
     </meta-name>
     <meta-value>
      Humanities and Social Sciences
     </meta-value>
    </custom-meta>
   </custom-meta-group>
  </article-meta>
  <notes notes-type="CrossLinking">
   <sec>
    <p>
     A correction to this article is available online at
     <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-025-58771-w">
      https://doi.org/10.1038/s41467-025-58771-w
     </ext-link>
     .
    </p>
   </sec>
  </notes>
 </front>
 <body>
  <sec id="Sec1" sec-type="introduction">
   <title>
    Ujumbe
   </title>
   <p id="Par3">
    Umri wa kijamii kulingana ulikuwa kuzitanda duniani kote. Kwa sababu hiyo, kipato cha matatizo yanayohusiana na umri na muda uliyopigwa kujikuna na matatizo yanayohusiana na umri, hasa kufika na nguvu na kushuka kwa akili, kimeongezeka. Kipato cha dementia kimeongezeka duniani kote, lakini kama kijamii kuzitanda, kujihusisha na mabadiliko yanayohusiana na umri ambayo yanaweza kuzitokea kama sehemu ya uzalishaji wa umri itakuwa muhimu zaidi kwa maafisa na wataalamu wanaotafuta kusaidia watu wazee. Mafunzo yanaweza kusimamia kufika na nguvu na kushuka kwa akili
    <sup>
     <xref ref-type="bibr" rid="CR1">
      1
     </xref>
     <xref ref-type="bibr" rid="CR2">
      2
     </xref>
     <xref ref-type="bibr" rid="CR3">
      3
     </xref>
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
     ,
     <xref ref-type="bibr" rid="CR5">
      5
     </xref>
    </sup>
    . Kuna sababu nyingi ambazo yanaweza kusababisha watu wazee kushindwa kufanya mazoezi, ambayo, kulingana na ufanisi wao ya kusaidia kuboresha afya na ufanisi, huchukuliwa kama changamoto. Mawasilisho yanayohakikisha kuwa yanatoa faida nyingi ya kifisadi na kiafya ni bado yanahitaji kujitolea.
   </p>
   <p id="Par4">
    Wanadamu hufika na nguvu ya msingi kwa kufika na umri, na hii inaweza kufikia hadi kusababisha sarcopenia. Proteini ya chakula ni muhimu sana kwa ufanisi wa nguvu ya msingi; hata hivyo, kuna sababu nyingi ambazo yanaweza kusababisha kupunguza kuzingatia proteini ya chakula katika umri wa kijana, hasa kujihusisha na kujitenga na jamii, dysphagia, na kusimamia kwa muda mrefu kwa mifupa
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
    </sup>
    . Hapa kati na kupunguza kuzingatia proteini ya chakula, utafiti ulivyotumika ulivyonyesha kuwa watu wazee wana anabolic resistance kwa kuzingatia proteini, ni mazungumzo yanayofikia nguvu ya msingi ya watu wazee kwa kuzingatia proteini ya nguvu ya msingi, hasa kulingana na watu wajuni
    <sup>
     <xref ref-type="bibr" rid="CR7">
      7
     </xref>
    </sup>
    . Hii imeleta kwa kuzitolea kuzingatia proteini ya kila siku ya 1–1.3 g/kg, kulingana na UK Reference Nutrient Intake ya wakulima wa 0.8 g/kg
    <sup>
     <xref ref-type="bibr" rid="CR8">
      8
     </xref>
    </sup>
    .
   </p>
   <p id="Par5">
    Ufanisi wa nguvu ya msingi unahifadhiwa kwa mazingira za ufanisi wa proteini ya nguvu na kuzingatia (MPS na MPB). Mazingira za MPS zinahifadhiwa kwa mazungumzo yanayofikia anabolic stimuli, hasa kuzingatia chakula na mazoezi. Mazingira za kuzingatia kuzingatia zinafikia kwa mada, kusimamia kwa muda, na mafua, ambazo watu wazee huwa wana kipato kubwa. Asili ya anabolic resistance ni muhimu, inahusu fisiologia ya kufika na umri na kusimamia kwa muda. Utafiti wa kuzingatia proteini kwa ufanisi wa nguvu imeonyesha matokeo yanayohakikisha zaidi wakati wanavyojungwa na mazoezi ya kuzingatia
    <sup>
     <xref ref-type="bibr" rid="CR8">
      8
     </xref>
    </sup>
    . Mazoezi ya kuzingatia imeonyeshwa kuwa ni mazungumzo yanayofikia anabolic kwa nguvu ya msingi, na proteini na mazoezi yanayonyesha mazungumzo yanayofikia kwa kujihusisha kwa kujihusisha
    <sup>
     <xref ref-type="bibr" rid="CR9">
      9
     </xref>
     ,
     <xref ref-type="bibr" rid="CR10">
      10
     </xref>
     ,
     <xref ref-type="bibr" rid="CR11">
      11
     </xref>
    </sup>
    .
   </p>
   <p id="Par6">
    Utafiti wa hivi karibuni unavyotumika unavyonyesha kuwa gut microbiome inaweza kuwa muhimu kwa ufanisi wa kiafya na kifisadi kwa kufika na umri. Gut microbiome inahifadhiwa kwa bakteria, archaea, virus, na eukaryotic microbes ambazo hufika katika gut, majimbo yao ya kujihusisha na mazingira yao
    <sup>
     <xref ref-type="bibr" rid="CR12">
      12
     </xref>
    </sup>
    . Rol yake ya kuhifadhi fisiologia ya salama ni mazingira yanayofikia kwa muda. Kwa kufika na umri, ufanisi wa gut microbiome unaweza kusababisha, kama unaweza kuzingatia kwa mada, dawa, na mabadiliko ya maisha, na kubadilika kwa kipato cha species richness na kuzingatia kati ya watu wawili
    <sup>
     <xref ref-type="bibr" rid="CR13">
      13
     </xref>
     ,
     <xref ref-type="bibr" rid="CR14">
      14
     </xref>
     ,
     <xref ref-type="bibr" rid="CR15">
      15
     </xref>
     ,
     <xref ref-type="bibr" rid="CR16">
      16
     </xref>
    </sup>
    . Ufanisi wa gut microbiota wa kubadilisha fisiologia imeonyeshwa kwa mazungumzo ya faecal transplant ya animals ambazo yameonyesha mabadiliko ya body composition katika mzungumzo yameonyesha phenotype ya donor
    <sup>
     <xref ref-type="bibr" rid="CR17">
      17
     </xref>
    </sup>
    . Hii inaonyesha rol ya microbiota ya kuhifadhi metabolic phenotypes. Mazingira nyingi zinazohusiana na anabolic resistance zinazohusiana na gut microbiome zinazohusiana na kuzingatia kwa kipato cha mazingira nyingi
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
     ,
     <xref ref-type="bibr" rid="CR18">
      18
     </xref>
     ,
     <xref ref-type="bibr" rid="CR19">
      19
     </xref>
     ,
     <xref ref-type="bibr" rid="CR20">
      20
     </xref>
     ,
     <xref ref-type="bibr" rid="CR21">
      21
     </xref>
    </sup>
    . Mifano yanaonyesha kuzingatia proteini na kuzingatia, gut barrier function, na mafua
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
    </sup>
    . Hapa kati, kuna matokeo yanayonyesha kuwa gut microbiome inaweza kuhifadhi nguvu ya msingi kwa mazingira za kuzingatia
    <sup>
     <xref ref-type="bibr" rid="CR22">
      22
     </xref>
     ,
     <xref ref-type="bibr" rid="CR23">
      23
     </xref>
    </sup>
    .
   </p>
   <p id="Par7"/>
   <p id="Par8">
    Uchunguzi huu unahitaji kuchunguza kama mabadiliko ya mikrobiota ya mifupa kwa kutumia prebiotiki unaweza kubadilisha ufanisi wa misuli (kutokana na muda wa kujifungua mara tano, ambayo ni alama ya nguvu ya misuli) mara tano kulingana na placebo katika utafiti ambao wafanyikazi wote wanaonekana kutoa protini (amino acid zinazohusiana na misuli [BCAA]) na mazoezi ya upigaji. Utafiti ulikuwa tayari ili kutathmini kama kuongeza mabadiliko ya mikrobiota ya mifupa inaweza kuboresha mabadiliko ya ufanisi wa misuli ambazo yamekuwa mara nyingi kutokana na pamoja BCAA na upigaji. Matokeo ya mara mbili walikuwa ufanisi wa akili, nguvu ya kujikuta, battery ya mazoezi ya ufanisi wa muda mfupi, appetiti, na maelezo ya mikrobiota ya mifupa. Kuzungumza na twins, ambao wanaonekana kwa kawaida kwa kifaktari cha jinsi na mazingira, imekuwa na maana kwa mifano ya utafiti.
   </p>
  </sec>
  <sec id="Sec2" sec-type="results">
   <title>
    Matokeo
   </title>
   <p id="Par9">
    Jumla ya watu 626 wamechunguza kwa uwezo wa kujihusisha, ambao 72 wameingizwa kwa mafanikio (36 maria). Figure
    <xref ref-type="fig" rid="Fig1">
     1
    </xref>
    inaonyesha mwenendo wa wafanyikazi kwa kulingana na utafiti. Uingiziko ulifunguka Mei 2021. Tarehe ya mzunguko wa kwanza kwa mwanafungo wa kwanza ilikuwa 17/05/2021, na tarehe ya mzunguko ya pili (ya mwisho) kwa mwanafungo wa mwisho ilikuwa 20/12/2021. Table
    <xref ref-type="table" rid="Tab1">
     1
    </xref>
    inaonyesha sifa za mfanikio ya wafanyikazi kwa awali. Wafanyikazi walikuwa na miaka 73 (ambapo muktadha ni 63–83) na walikuwa 78% wanawake (56/72). Mipaka walikuwa na uhamiaji kwa awali, kama ulikuwa na tafadhali, kulingana na mifano ya maria. Hata hivyo, kuna tofauti kati ya mipaka mbili kwa anwani ya appetiti ya SNAQ. Kwa hiyo, hii ilikuwa imetambuliwa kwenye tathmini zifuatazo kama chanzo cha kujihusisha. Appetiti ilikuwa imetambuliwa kwenye utafiti kwa sababu tunajua kwamba mifano ya mikrobiota ya mifupa na uingiziko wa protini huathiriwa na appetiti
    <sup>
     <xref ref-type="bibr" rid="CR28">
      28
     </xref>
    </sup>
    .
    <fig id="Fig1" position="float">
     <label>
      Fig. 1
     </label>
     <caption xml:lang="en">
      <title>
       Uraia wa wafanyabiashara.
      </title>
      <p>
       Uraia wa wafanyabiashara kwa mchakato, hasa kujumlisha uchanganuzi wa kuhimili, uchaguzi, kufuata na uanalizi.
      </p>
     </caption>
     <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-46116-y/41467_2024_46116_Fig1_HTML.png" mime-subtype="PNG" specific-use="web"/>
    </fig>
   </p>
   <p id="Par10">
    Supplementary Table
    <xref ref-type="supplementary-material" rid="MOESM1">
     S4
    </xref>
    inaonyesha data ya chakula zinazochakuliwa na wafanyikazi kwa awali na mwishoni kwa utafiti kwa kutumia software ya myfood24 ya mtandaoni. Supplementary Table
    <xref ref-type="supplementary-material" rid="MOESM1">
     S5
    </xref>
    inaonyesha data hii pia na waleo ambao walikuwa na maonyesho zaidi zimeondolewa kwenye tathmini. Hapana waleo ambao walikuwa na maonyesho chache zimehujulikiwa. Supplementary Table
    <xref ref-type="supplementary-material" rid="MOESM1">
     S6
    </xref>
    inaonyesha data ya chakula kulingana na mipaka ya utafiti. Hapana tofauti kati ya prebiotiki na mipaka ya placebo kwa awali au mwishoni kwa utafiti kwa kila ukurasa wa chakula ya fiba. Kwa kawaida, kuna tofauti ndogo kati ya uingiziko wa nishati kwa awali na mwishoni kwa utafiti, ambayo inaonekana kumetolewa na tofauti katika mipaka ya prebiotiki (−132.4 kcal/d). Tofauti hii ndogo kati ya mipaka ya prebiotiki na placebo (75.6 kcal/d) inaonekana kwenye hadi za kosa kwa ukurasa wa uingiziko wa nishati. Tofauti hii ndogo ya uingiziko wa nishati kuzingatia muda, ambayo inaweza kujulikana kwa njia ya athari ya inulin kwenye appetiti, inaweza kusaidia kuzingatia athari kwenye nguvu ya misuli. Hata hivyo, tunajua hadi za kujulikana ya tofauti ndogo hizi ya uingiziko wa nishati hata wakati wa kutumia tekniki za kujulikana za nishati za kipimo cha kawaida katika watu wanaokishi huru. Hapana tofauti muhimu kati ya uzito (kg) au indeksi ya uzito kati ya awali na mwishoni kwa utafiti katika mipaka yoyote (Supplementary Table
    <xref ref-type="supplementary-material" rid="MOESM1">
     S6
    </xref>
    )
    <sup>
     <xref ref-type="bibr" rid="CR29">
      29
     </xref>
     ,
     <xref ref-type="bibr" rid="CR30">
      30
     </xref>
    </sup>
    .
   </p>
   <p id="Par11">
    Supplementary Table
    <xref ref-type="supplementary-material" rid="MOESM1">
     S7
    </xref>
    inaonyesha matokeo ya swali za mizizi ya mifupa, ambako hapana tofauti zimepitwa kati ya mipaka za utatuzi kwa kila swali kuhusu mizizi ya mifupa. Supplementary Table
    <xref ref-type="supplementary-material" rid="MOESM1">
     S1
    </xref>
    inaonyesha sifa za demografi ya waleo ambao wameingizika au wamekataa kujihusisha kulingana na waleo ambao wameingizika, kutumia data ya muda wa TwinsUK. Kundi linalo watu wengi wanawake kwa sababu ya sababu za historia. Wafanyikazi walikuwa wajuniori na walikuwa wanaume zaidi kuliko kundi la kawaida la TwinsUK. Tofauti muhimu iliyobaki baada ya kusambaza tofauti ya jinsi kwa miaka na tofauti ya miaka kwa jinsi (Supplementary Table
    <xref ref-type="supplementary-material" rid="MOESM1">
     S1
    </xref>
    ).
   </p>
   <sec id="Sec3">
    <title>
     Mamboleo na ushirikiano
    </title>
    <p id="Par12">
     Kuna tofauti zaidi za matukio madogo (kama vile kujikura kwenye mifupa) katika mipaka ya prebiotiki kuliko mipaka ya placebo, lakini hapana tofauti kati ya uhamiaji, kusababisha kwamba dawa zote zilikuwa zinaweza kutumika vizuri. Hapana wafanyikazi waleo ambao wamewasilisha ‘matukio ya mifupa’ kama sababu ya kutokujihusisha na utatuzi wa mfanikio katika mipaka yoyote. Hapana matukio ya kibaya kubwa zilizotokea.
    </p>
    <p id="Par13">
     Jadual
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     inayohusu idadi ya matukio makubwa kwa kila mwanga na ushirikiano na uharakishaji. Jadual
     <xref ref-type="supplementary-material" rid="MOESM1">
      S2
     </xref>
     inaorodheshwa matukio yoyote yaliyonilazwa na wafanyabiashara. Tukajipatia pia mabadiliko ya dawa (Jadual
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     ) wakati wa utafiti, ambayo ilikuwa wengi sana.
    </p>
   </sec>
   <sec id="Sec4">
    <title>
     Matokeo ya kwanza na ya pili
    </title>
    <p id="Par14">
     Matokeo ya vifaa vya mifano vya mizizi kwa matokeo ya kwanza na ya pili yameonyeshwa katika Jadual
     <xref ref-type="table" rid="Tab3">
      3
     </xref>
     , kuhusu matokeo yote ya kufuata (ITT) na ya kujitolea (PP). Ilikuwa kuna tofauti kubwa kati ya matokeo ya ITT na PP. Ilikuwa kuna tofauti kati ya prebiotiki na placebo kwa matokeo ya kwanza ya muda wa kujifungua (maana ya mabadiliko kati ya awali na mwisho wa utafiti 0.88 s [SD 2.16] kwa prebiotiki na 1.12 s [SD 1.52] kwa placebo;
     <italic>
      p
     </italic>
     = 0.631), wala kwa matokeo ya pili ya uharakishaji wa kifisikili (nguvu ya kujikuta, battery ya uharakishaji wa kifisikili ya muda mfupi, na IPAQ MET dakika) au anwani ya appetiti ya SNAQ.
    </p>
    <p id="Par15">
     Mwanga wa prebiotiki uliyonyesha tofauti kubwa kwa anwani ya kwanza ya ufanisi kulingana na placebo (
     <italic>
      β
     </italic>
     = −0.482; 95% CI −0.813, −0.141;
     <italic>
      p
     </italic>
     = 0.014). Pia, uchambuzi wa kifanisi wa ufanisi uliyotumika (uchambuzi wa kumbukumbu) ulikuwa na tofauti kubwa kwenye idadi ya matukio ya kosa kwa mwanga wa prebiotiki kulingana na placebo (
     <italic>
      β
     </italic>
     = 7.55; 95% CI: 4.65–10.46;
     <italic>
      p
     </italic>
     = 0.001). Uchambuzi huu wa kifanisi una umuhimu wa kliniki, uliyotambuliwa kama anwani ya kwanza ya dementia ya Alzheimer
     <sup>
      <xref ref-type="bibr" rid="CR31">
       31
      </xref>
      ,
      <xref ref-type="bibr" rid="CR32">
       32
      </xref>
     </sup>
     . Ukuaji wa data ulikuwa juu kwa uchambuzi wa CANTAB kulingana na athari nyingine za matokeo. Hakujulikana tofauti kubwa wakati wa usimbaji wa sifa za demografi ya wale ambao waliamaliza uchambuzi wa kifanisi kulingana na wale ambao hawajamaliza, bali hakuna sifa hasa zinazoweza kuhakikisha ukakatili wa data ya uchambuzi wa kifanisi, kama inavyoonyeshwa katika Jadual
     <xref ref-type="supplementary-material" rid="MOESM1">
      S3
     </xref>
     <sup/>
     . Hakujulikana matokeo yoyote ya baada ya baada.
    </p>
   </sec>
   <sec id="Sec5">
    <title>
     Matokeo ya gut microbiome
    </title>
    <p id="Par16">
     Kulingana na matokeo ya pili ya uharakishaji wa kifisikili, usalama wa gut microbiome na ufanisi uliyotathminiwa na kulipwa kutoka kwa sampuli za stool. Data za usalama za kujifunza zimepewa kutoka kwa sampuli zote, kwa wastani wa 21.6 M read pairs kwa kila sampuli na ukurasa wa chini wa 11.7 M read pairs. (Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S1
     </xref>
     ). Kwa wastani 17.9 M read pairs kwa kila sampuli zinaweza kujitambulisha kwenye catalogue ya gene, yanayoweza kutoa kwa wastani 82.8% ya HQNH reads (ukurasa wa chini = 68.5%, tazama Jadual
     <xref ref-type="supplementary-material" rid="MOESM1">
      S8
     </xref>
     ), yanayoweza kutoa 1494 MGS. Sampuli zingine zimekuwa na kibinafsi kubwa kwa familia
     <italic>
      Bacteroidaceae
     </italic>
     ,
     <italic>
      Oscillospiraceae
     </italic>
     , na
     <italic>
      Lachnospiraceae
     </italic>
     , kwa sababu ya tofauti kati ya watu, kama ulikuwa unavyotarajiwa.
    </p>
    <sec id="Sec6">
     <title>
      Uhusiano wa gut microbiota kati ya marafiki
     </title>
     <p id="Par17">
      Uhusiano kati ya usalama wa gut microbiome ya twin pairs katika utafiti na mwisho wa utafiti uliyotathminiwa, na tathmini ya heritability uliyofanyika (Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S2
      </xref>
      ). Ingawa kuna uwezo wa tofauti kati ya twin pairs katika usalama wa gut microbiome (Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S3
      </xref>
      ), tuliambatana kwamba usalama wa gut microbiome ya twin pairs ulikuwa na tofauti kubwa kulingana na usalama wa gut microbiome ya watu wanaohusiana kwa kawaida kwa awali (
      <italic>
       U
      </italic>
      = 55579,
      <italic>
       p
      </italic>
      = 0.0026) na mwisho wa utafiti (
      <italic>
       U
      </italic>
      = 44342,
      <italic>
       p
      </italic>
      = 0.00072), kwa kutumia Bray–Curtis dissimilarity (Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S4
      </xref>
      ).
     </p>
     <p id="Par18"/>
    </sec>
    <sec id="Sec7">
     <title>
      Matokeo ya gut microbiota kati ya prebiotiki na placebo
     </title>
     <p id="Par19">
      <fig id="Fig2" position="float">
       <label>
        Fig. 2
       </label>
       <caption xml:lang="en">
        <title>
         Uchaguzi wa wafanyabiashara wa kizazi kizazi kati ya vifaa vya prebiotiki na vya placebo, hasa data kutoka mwisho wa mchakato au tofauti kati ya awali na mwisho wa mchakato.
        </title>
        <p>
         Uchaguzi wa wafanyabiashara wa kizazi kizazi kwa uwekezaji wa kutosha (a) na kutosha (p) ya mikoa ya bakteria kati ya vifaa vya mchakato vya kizazi kizazi au mwisho wa mchakato iliyoongezwa kwa uwekezaji wa awali wa mikoa. Uchaguzi wa tofauti kati ya mikoa ya gut microbiome ilifanyika kwa mada ya uhamiaji wa mada wa uhamiaji ili kuongeza tofauti ya uhamiaji. Hapana tofauti maana kati ya vifaa vya awali au gut metabolic modules, gut–brain modules, au alpha diversity. Tofauti ya athari ni tofauti za uhamiaji zinazoungwa kwa mada ya uhamiaji ambazo tofauti maana zinazohusu tofauti maana (blue) zinaonesha tofauti maana zinazojulikana kwa vifaa vya placebo na tofauti maana zinazohusu tofauti maana (red) zinaonesha tofauti maana zinazojulikana kwa vifaa vya prebiotiki.
        </p>
       </caption>
       <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-46116-y/41467_2024_46116_Fig2_HTML.png" mime-subtype="PNG" specific-use="web"/>
      </fig>
     </p>
     <p id="Par20"/>
     <p id="Par21"/>
    </sec>
    <sec id="Sec8">
     <title>
      Matumbo ya gut microbiota na nguvu ya misuli
     </title>
     <p id="Par22"/>
    </sec>
    <sec id="Sec9">
     <title>
      Matumbo ya gut microbiota na ujuzi
     </title>
     <p id="Par23">
      Kutumia mbinu ya uchanganuzi wa uhusiano kati ya uwezo wa kifisikili (muda wa kujifungua kiti) na sifa za mikrobiota kama ilivyotolewa hapa juu, tuliangalia sifa tano za mikrobiota zilizokuwa na uhusiano mkubwa na uwezo wa akili (anwani ya uwezo wa akili) wakati wa kurekebisha matumizi ya mikoa na uhusiano wa mizizi na mizizi na mizizi (Supplementary Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S10
      </xref>
      ). Hili ilikwani kuhusu phylum Actinobacteria (
      <italic>
       r
      </italic>
      = −0.323;
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0447), ambalo ilikuwa na tofauti kubwa katika kundi la prebiotiki kulingana na placebo mara nyingi mwishoni ya utafiti. Uhusiano wa maendeleo ya anwani ya uwezo wa akili ilikuwa pia na uhusiano na tofauti katika nishati ya kujifunza ya Veillonellaceae na kundi yake ya kujifunza ya Veillonelalles kutoka kwa mada ya kuanza hadi mwishoni wa utafiti (
      <italic>
       r
      </italic>
      = 0.585,
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0555, na
      <italic>
       r
      </italic>
      = 0.543,
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0772, kwa ujumla (Supplementary Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S9
      </xref>
      ).
     </p>
    </sec>
   </sec>
  </sec>
  <sec id="Sec10" sec-type="discussion">
   <title>
    Uchunguzi
   </title>
   <p id="Par24">
    Uzima unajihusisha na kuongezeka kwa uchunguzi na kusimama kwa uwezo wa akili, ambavyo zote zinaweza kujumuisha roli ya mikrobiota ya mgavu. Katika RCT hii, tulionyesha kuwa prebiotiki ilikuwa imetolewa vizuri kwa kawaida na ilitoa athari ya kubadilika kwa mikrobiota ya mgavu, hasa kwa kuongezeka kwa nishati ya kujifunza ya
    <italic>
     Bifidobacterium
    </italic>
    <sup/>
    . Hata hivyo, hakuwa kuna tofauti kubwa katika anwani ya kwanza ya muda wa kujifungua kiti kati ya prebiotiki na placebo, lakini prebiotiki iliyasaidia uwezo wa akili kulingana na placebo.
   </p>
   <sec id="Sec11">
    <title>
     Nguvu ya misuli na fidi
    </title>
    <p id="Par25">
     Hakujapewa dalili yoyote ya kuwa prebiotiki hii iliyasaidia uwezo wa misuli kulingana na placebo kwa muda wa 12 wiki, hasa kwa anwani ya kwanza ya muda wa kujifungua kiti. Pia, hakuwa kuna athari ya prebiotiki kwenye anwani zingine za sekondari zinazohusiana na uwezo wa misuli na kazi kama ni nguvu ya kujifunga kwa mikono, SPPB, au kazi ya kifisikili (IPAQ).
    </p>
    <p id="Par26">
     Muda wa 12 wiki wa kudhibiti ilichaguliwa kulingana na utafiti zilizopita kuhusu prebiotiki
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
      ,
      <xref ref-type="bibr" rid="CR33">
       33
      </xref>
     </sup>
     . Hata hivyo, hakuna zilizofokusia kwa uwezo wa misuli kama anwani ya kwanza. Muda huu unaweza kubadilika kwa muda wa kurekebisha misuli, na inawezekana kuwa muda wa kudhibiti wa muda mrefu unahitaji kujulikana ili kujifunza athari za kubadilika kwa mikrobiota ya mgavu kwa uwezo wa misuli. Ingawa mafadhaili ya EWGSOP2 yanarekebisha muda wa kujifungua kiti kama anwani ya uwezo wa misuli, kazi zinazofuata zinapaswa kuhakikisha kuongeza anwani ya kujifunza ya misuli ya kifisikili ambayo inaweza kujifunza tofauti zisizo nzuri kwenye misuli (kama vile quadriceps) pamoja na muda wa kujifungua kiti. Ingawa inahitaji kujitambuliwa kwa kawaida kwa watu wazima, muda wa kujifungua kiti ni anwani ya jumla, inayotumika kwa nguvu, mizizi, macho, na kwa kawaida na anwani ya kifisikili. Uhusiano wa tofauti kubwa imejulikana kwenye anwani za uwezo wa misuli kwa watu wazima, ingawa anwani kama muda wa kujifungua kiti na nguvu ya kujifunga kwa mikono ni anwani ambazo yanaweza kujitumika kwa kawaida katika mazingira ya kliniki, anwani zingine za kifisikili na zingine zinazohusiana na uwezo wa misuli zinapaswa kuhakikishwa katika utafiti wa muda mrefu zinazotaka kujulikana kuhakikisha ufanisi wa mikrobiota ya mgavu katika kubadilisha anwani za misuli kwa watu wazima
     <sup>
      <xref ref-type="bibr" rid="CR34">
       34
      </xref>
     </sup>
     .
    </p>
    <p id="Par27">
     Pia, hisabati ya namba ya sampuli yaliyochaguliwa iliyoandaliwa kulingana na utafiti zilizopita zilizotumia muda wa kujifungua kiti kama anwani ya kwanza
     <sup>
      <xref ref-type="bibr" rid="CR35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="CR36">
       36
      </xref>
      ,
      <xref ref-type="bibr" rid="CR37">
       37
      </xref>
     </sup>
     . Hata hivyo, hakuna utafiti uliyotumia kudhibiti ya mikrobiota, na kwa hivyo inawezekana kuwa utafiti ulikuwa na nguvu nyingi. Hakika, tu moja kati ya tano (14/65; 8 katika kundi la prebiotiki, 6 katika kundi la placebo,
     <italic>
      p
     </italic>
     = 0.68) ya wale waliopata anwani ya muda wa kujifungua kiti kwa mada ya kuanza na mwishoni wa utafiti walipata tofauti ya 20%, ambayo ilivyotumika katika hisabati ya namba ya sampuli.
    </p>
    <p id="Par28">
     Dose ya prebiotic ilifundishwa kulingana na majaribio yanayotumika katika majengo ya kujifunza
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
     </sup>
     . Tafkika ya Tandon et al. (2019) alitathmini dosing ya fructooligosaccharide (FOS) kwenye watu wazima na kurejelea hakuna tofauti za kina statistiki kati ya mabadiliko ya gut microbiota kulingana na 2.5 g/d, 5 g/d na 10 g/d (sachets za PROMOTe zina 7.5 g/d), lakini kuna mifano ya tofauti katika abundance ya
     <italic>
      Lactobacillus
     </italic>
     kwenye kundi la dosing ya juu
     <sup>
      <xref ref-type="bibr" rid="CR38">
       38
      </xref>
     </sup>
     . So et al. walifanya meta-analysis ya uhamiaji wa dietary fibre, mengi ya ambayo ilikuwa na inulin na/FOS, na walipata hakuna tofauti katika athari kwenye abundance ya
     <italic>
      Bifidobacterium
     </italic>
     kulingana na dosing zinazotofautiana
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
     </sup>
     . Walihakikisha kuwa inaweza kuwa kuna hadi ya kiasi cha fibre ambacho Bifidobacterium inaweza kuhifadhi, au labda ukosefu wa athari ya dosing inaweza kuwa kulingana na pumziko la percentage kutoka kwenye baseline hasa kuliko dosing ya uhamiaji
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
     </sup>
     . Matokeo yanayotolewa hapa yanatoa maoni kuwa dosing ya 7.5 g/d ilikuwa kifupi kufanya mabadiliko ndani ya gut microbiome. Lakini, hakuna litrature kuhusu dosing ya kifupi ya prebiotics kulingana na athari za physical kama muscle strength. Inaweza kuwa dosing, wakati kifupi kufanya mabadiliko ndani ya gut microbiome, ilikuwa si kifupi kutoa athari muhimu kulingana na muscle strength ndani ya kundi cha volunteers wa afya.
    </p>
    <p id="Par29">
     Mwishowe, wakati prebiotic uliyotumika katika majaribio haya ulitathminiwa kuongeza grip strength, levels ya exhaustion, na frailty index katika majaribio mengine ya watu wazima, inaweza kuwa prebiotic ya inulin/FOS si ya kutosha kufanya athari kwenye afya ya muscle, na tafkika zingine zinahitaji kujengwa ili kuthibitisha prebiotic bora kwa maono haya
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
      ,
      <xref ref-type="bibr" rid="CR26">
       26
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec12">
    <title>
     Ujuzi
    </title>
    <p id="Par30">
     Kulingana na athari za mara mengine, prebiotic uliongeza cognition kulingana na placebo. Kwa kutumia factor score ili kujumlisha viwango vya CANTAB cognitive battery, ni ngumu kutoa maoni kama athari haya ni na maana kliniki. Viwango vya kognitivi vya pekee vilivyopatikana athari muhimu katika kundi la prebiotic kulingana na placebo vilikuwa ni namba ya errors katika Paired Associates Learning test, ambayo ni test ya memory ambayo inafokusika kwa kutosha kwenye visual memory na new learning
     <sup>
      <xref ref-type="bibr" rid="CR40">
       40
      </xref>
     </sup>
     . Viwango hivi vilivyotathminiwa pia kama mara ya kwanza ya mapato ya maambukizi kama Alzheimer’s Disease
     <sup>
      <xref ref-type="bibr" rid="CR31">
       31
      </xref>
      ,
      <xref ref-type="bibr" rid="CR32">
       32
      </xref>
     </sup>
     .
    </p>
    <p id="Par31">
     Mfumo wa gut–brain axis, ambapo microbiota inathibitisha njia za bidirectional gut-brain, imekuwa imetathminiwa katika miaka ya hivi karibuni
     <sup>
      <xref ref-type="bibr" rid="CR41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="CR42">
       42
      </xref>
     </sup>
     . Inaweza kujulikana kuwa kuna njia tatu za kina muhimu kwa bidirectional communication: neural, immune, na endocrine
     <sup>
      <xref ref-type="bibr" rid="CR41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="CR43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="CR44">
       44
      </xref>
     </sup>
     . Kwa kweli, kuna mifumo yanayofua kwa sana yanayosaidia uhamiaji ambayo zinatathmini gut microbiome (kulingana na prebiotic) kwenye kuboresha cognition
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
     </sup>
     . Desmedt et al. walireviesa tafkika za prebiotics kwenye affect na cognition ya binadamu na walipata 14 tafkika yanayokuwa na tofauti kubwa katika methodologies, outcomes, dosing ya prebiotic, na duration ya uhamiaji
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
     </sup>
     . Mengi ya tafkika hayo zilifokusika kwenye mood na affect lakini kuna athari zinazopatikana kwenye verbal episodic memory na recognition. Hakuna tafkika yoyote iliyotumika CANTAB cognitive tests. Kwa hiyo, ili kuthibitisha matokeo yetu, tafkika kubwa yanayojumuisha viwango vya kognitivi vya kina, pamoja na viwango vya effect na attention, na mikakati ya microbiome (compositional na functional) inahitaji kujengwa.
    </p>
   </sec>
   <sec id="Sec13">
    <title>
     Gut microbiome
    </title>
    <p id="Par32"/>
    <p id="Par33">
     Kwa njia ya kuburudisha, hasa kwa sababu mtoto mmoja kutoka kwa kila mizizi alipewa prebiotiki na mwingine placebo, hakuwa na mabadiliko yanayohusiana na kutosha kati ya mizizi katika muda wa mwisho wa utafiti. Kazi zilizofanyika kwa awali yameonyesha kwamba gut microbiome inaundwa na geneti na mazingira ya mwaka wa kwanza, kwa kuchukua uwezo wa kujifunza na kuzingatia jamii ya ekolojia. Kwa hiyo, muda wa 12 wiki wa uwezo wa prebiotiki ulikuwa bila shaka sana kusambaza utambulisho kati ya mizizi, ambao wanaishiriki geneti, ujuzi wa mazingira ya mwaka wa kwanza, na mara nyingi mafanikio mengine mengi. Analizi ya heritability yameonyesha kwamba baadhi ya taxa ambazo tulipata kubadilika kwa muda wa utafiti (kama vile
     <italic>
      Bifidobacterium
     </italic>
     ) ilikuwa ina heritability, ambayo inaonyesha kwamba mifano yetu ya utafiti ulikuwa umetengenezwa kwa kutumia mizizi, na mifano ulikuwa unaweza kuboresha uwezo wetu wa kuchunguza athari
     <sup>
      <xref ref-type="bibr" rid="CR52">
       52
      </xref>
      ,
      <xref ref-type="bibr" rid="CR53">
       53
      </xref>
      ,
      <xref ref-type="bibr" rid="CR54">
       54
      </xref>
      ,
      <xref ref-type="bibr" rid="CR55">
       55
      </xref>
     </sup>
     .
    </p>
    <p id="Par34">
     Kutoka kwenye utunzo hadi
     <italic>
      funguo
     </italic>
     ya gut microbiota, iliyotokana na mizigo mengi ya GMM zilizotambuliwa kuwa zina uhusiano wa kubadilika na uwezo wa kujenga kifisadi kwa kawaida ya mifano na utambulisho wa mizizi (Supplementary Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S8
     </xref>
     ). Kati ya hayo ilikuwa mizigo ya metabolism ya amino acids na carbohydrates, pamoja na mizigo ya pentose phosphate; mizigo hayo yanatoa vinywaji kwa biosynthesis ya amino acids na vyanzo kwa anabolism na ni muhimu katika anabolism ya skeletal muscle
     <sup>
      <xref ref-type="bibr" rid="CR56">
       56
      </xref>
      <xref ref-type="bibr" rid="CR57">
       57
      </xref>
      ,
      <xref ref-type="bibr" rid="CR58">
       58
      </xref>
     </sup>
     . Matoe hii inaongeza uzito kwa maelezo ya gut-muscle axis, ambayo inaamini kwamba kuna uhusiano wa kubadilika kati ya gut microbiota na skeletal muscle, ambayo inaweza kuwa na maana ya mekaniki katika atrophy ya skeletal muscle ya umri, na inahitaji kuchunguza zaidi katika utafiti zinazofuata zinazofokusia kwenye aina ya gut microbiome katika anabolic resistance ya skeletal muscle ya umri
     <sup>
      <xref ref-type="bibr" rid="CR18">
       18
      </xref>
     </sup>
     .
    </p>
    <p id="Par35">
     Kuna maelezo mengi yanayofuata kuhusu gut-brain axis, mfumo wa mawasiliano wa kubadilika kati ya nervous systems ya central na enteric, ambapo gut microbiota ina ufanisi mkubwa
     <sup>
      <xref ref-type="bibr" rid="CR59">
       59
      </xref>
     </sup>
     . Hapa, tumeonyesha uhusiano wa kubadilika kati ya zaidi kujenga kifisadi na uwezo wa Actinobacteria kwa muda wa mwisho wa utafiti, hata baada ya kuchambua uwezo wa kujenga kifisadi kwa muda wa kwanza, mifano, na utambulisho wa mizizi (Supplementary Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S10
     </xref>
     ). Actinobacteria imeonyeshwa kuwa ina uhusiano na kifisadi kwa mahali mengine na imeonyeshwa kuwa ina uhusiano na Alzheimer’s disease na Parkinson’s disease
     <sup>
      <xref ref-type="bibr" rid="CR60">
       60
      </xref>
      ,
      <xref ref-type="bibr" rid="CR61">
       61
      </xref>
      <xref ref-type="bibr" rid="CR62">
       62
      </xref>
     </sup>
     . Mpelezo wa uhusiano unavii mbali kati ya utafiti. Hata kwa hivyo, imeonyeshwa kuwa ina uhusiano na hali za maradhi, utafiti moja wa watu 39 wameonyesha kwamba uwezo wa kujenga kifisadi zaidi imeonyeshwa kuwa ina uhusiano na kujenga kifisadi zaidi na kujitahidi
     <sup>
      <xref ref-type="bibr" rid="CR63">
       63
      </xref>
     </sup>
     . Actinobacteria ni phylum ambapo genera
     <italic>
      Bifidobacterium
     </italic>
     inaingia; kwa hiyo, ni muhimu kutoa kumbukumbu kwamba utafiti mengi wa uwezo wa
     <italic>
      Bifidobacterium
     </italic>
     -based probiotic imeonyesha athari zinazohusiana na kifisadi
     <sup>
      <xref ref-type="bibr" rid="CR64">
       64
      </xref>
     </sup>
     . Hataria zaidi zinahitaji kuchunguza uhusiano wa Actinobacteria na kifisadi.
    </p>
   </sec>
   <sec id="Sec14">
    <title>
     Uwezo wa utafiti
    </title>
    <p id="Par36">
     Mifano ya kuburudisha ya utafiti huu ni nguvu na inaonyesha kwamba mazungumzo yanayotolewa kwa njia ya kuburudisha yanaweza kujitolewa kwa njia sahihi kwa watu wazee, kwa kuchukua data kubwa na uhamasisho mzuri. Mifano ya utafiti hii ina umuhimu wa kuboresha kutosha ya watu wazee katika utafiti. Viongozi wa taasisi zinazostahimili zimepiga neno la kuboresha kutosha katika utafiti, kuzungumza watu wazee kama kundi la lisilo linaloservishwa, na kusikiliza kutosha kama ni mfano muhimu ya kumaliza kwenye shiriki
     <sup>
      <xref ref-type="bibr" rid="CR65">
       65
      </xref>
      ,
      <xref ref-type="bibr" rid="CR66">
       66
      </xref>
     </sup>
     . Pia, maelezo ya kutosha ya kujitolea zilizotengenezwa ili zisikilize kutosha kama zinavyo zinaweza kujitolea kwa watu wazee, hasa wale wanaozindua na kutosha na maradhi mengi.
    </p>
    <p id="Par37"/>
   </sec>
   <sec id="Sec15">
    <title>
     Uwezo na matatizo
    </title>
    <p id="Par38"/>
    <p id="Par39">
     Mfumo wa utafiti wa mbali ni nguvu, kwa sababu kuna haja inayohusishwa na uundaji wa utafiti wa kujenga kwa kawaida baada ya COVID, ambayo inaongeza hasara ya safari kwa wazee ambao hawawezi kujitahidi kusafiri hadi mashariki ya hospitali au ambao wanajulikana kuwa na matatizo ya kumgeukia. Utafiti wa mbali pia inaweza kusababisha hasara ya gharama za utafiti. Hata hivyo, utafiti wa mbali inaweza kusambaza wale ambao hawana ujuzi wa teknolojia au ambao hawana fursa ya kufungua kompyuta/tablet na/au internet. Hii inaweza kusababisha hasara zaidi kwa wale ambao wana elimu ya chini, maambukizi zaidi, Kiingereza kama lugha ya pili, na mifano mengine yanayohusiana
     <sup>
      <xref ref-type="bibr" rid="CR66">
       66
      </xref>
     </sup>
     . Ujumbe wa data pia inaweza kuwa na ujumla zaidi kuliko wakati wa kufanya kazi kwa mawasiliano, hata hivyo kutumia video teleconferencing imeongeza hali hii.
    </p>
    <p id="Par40">
     Mfumo wa utafiti wa mbali imeongeza hasara ya kutatua kiasi cha msomo, ambao ni hasara. Ingawa kiasi cha msomo ni moja ya sifa za kuhudumia ya sarcopenia, mawasiliano ya European Working Group for Sarcopenia of Older Persons 2 (EWGSOP2) yanazungumza kwa uwezekano wa nguvu ya msomo kama ni muhimu zaidi kwa kujihusisha
     <sup>
      <xref ref-type="bibr" rid="CR67">
       67
      </xref>
     </sup>
     . Utafiti zinazofuata za kuzungumza nyaraka zinazotumika kwa gut-muscle axis zinapaswa kujumuisha kiasi cha msomo kwa kujihusisha hali hii.
    </p>
    <p id="Par41">
     Kukosa data kwa CANTAB cognitive tests ilikuwa zaidi kuliko nyaraka mengine. Hili ilikuwa inawezekana kwa sababu ya hasara ya kufanya CANTAB nyumbani, ambayo inaweza kuwa na muda, na software haiwezi kufungua kwa vifaa vingine vya tablet. Baadhi ya wale ambao walikuwa wanatumia tablets hawakuweza kufanya software kufanya kazi kwenye vifaa vyao.
    </p>
    <p id="Par42">
     Uhusiano wa gut microbiome ulikuwa tayari tayari mara mbili, kwa mara ya kuanza na mwisho wa utafiti. Bila mfano wa kati wa utafiti, hatuwezi kutoa maoni kuhusu kama au si kama matokeo ya gut microbiota kwenye mwisho wa utafiti yanayonyesha mapato ya mara kati ya uhusiano wa prebiotiki. Mfano wa kubwa na muda wa utafiti wa kubeba zaidi unaweza kuhitaji kujaribu hii. Pia, tathmini ya kazi ya gut microbiome katika utafiti huu inabinafsi kwenye data ya metagenomic bila kutoa matokeo. Utafiti zinazofuata zinaweza kuzungumza meta transcriptomics au metabolomics ya stool kwa kujihusisha hali hii zaidi. Maltodextrin ni placebo ambao inatumika mara nyingi katika utafiti za prebiotiki lakini ina matatizo, kwa sababu haiwezi kujumuisha kwa uwezekano wa energy na prebiotiki. Utafiti zinazofuata zinaweza kuzungumza placebo ambao inajumuisha kwa uwezekano wa energy kwa kujitafuta hali hii.
    </p>
    <p id="Par43">
     TwinsUK cohort, ambao wale ambao walitolewa walikuwa wameingizwa, ni wanawake wengi kwa sababu ya sababu za historia na ina bias ya volunteer wengi wa afya
     <sup>
      <xref ref-type="bibr" rid="CR68">
       68
      </xref>
     </sup>
     . Hata hivyo, inaonyesha kwa kawaida kwa watu wa UK
     <sup>
      <xref ref-type="bibr" rid="CR68">
       68
      </xref>
     </sup>
     . Utafiti huu ulikuwa na matumaini ya kuzungumza wale ambao wana miaka zaidi ya 60, kwa hivyo, si kuzungumza kwa vijana zaidi. Pia, wengi wana wanawake wengi ambao wanaweka hasara ya kawaida. Utafiti zinazofuata zinazohusiana na nafasi hii zinapaswa kujumuisha wakazi wa miaka ya kati, wazee zaidi, na wale ambao wana wanaume wengi.
    </p>
   </sec>
   <sec id="Sec16">
    <title>
     Jumla ya uchunguzi
    </title>
    <p id="Par44"/>
   </sec>
  </sec>
  <sec id="Sec17" sec-type="methods">
   <title>
    Uchaguzi
   </title>
   <p id="Par45"/>
   <p id="Par46"/>
   <p id="Par47"/>
   <p id="Par48"/>
   <p id="Par49">
    Vyanzo vya kumbukumbu kutoka kwenye kitambaa cha CANTAB vilikuwa na vyanzo vya kazi ya kifahamu, kama vile One Touch Stockings of Cambridge na vyanzo vya kumbukumbu ya maeneo, na vyanzo vya kumbukumbu, kama vile spatial span, pattern recognition memory, na paired associates learning
    <sup>
     <xref ref-type="bibr" rid="CR40">
      40
     </xref>
    </sup>
    . Data za diary ya mlozi ya siku tatu ziliingizwa na zilianalizwa kwenye software ya mtandaoni
    <italic>
     MyFood24
    </italic>
    <sup>
     <xref ref-type="bibr" rid="CR73">
      73
     </xref>
     ,
     <xref ref-type="bibr" rid="CR74">
      74
     </xref>
    </sup>
    .
   </p>
   <p id="Par50"/>
   <sec id="Sec18">
    <title>
     Maoni ya kujumuisha/kusambaza
    </title>
    <p id="Par51"/>
   </sec>
   <sec id="Sec19">
    <title>
     Uchaguzi wa utafiti
    </title>
    <p id="Par52"/>
    <p id="Par53"/>
    <p id="Par54">
     Wafanyikazi wote walitolewa kuhifadhi saketi zozote zilizobakia mwishoni wa muda wa utambulisho kama njia ya kuhakikisha uaminifu. Hata hivyo, wafanyikazi wote walitolewa kujitahidi kufanya mazoezi ya upigaji mara mbili kwa wiki mara kwa mara wakati wote wa utambulisho na walipatikana na maelezo ya kitabu kuhusu hilo kuanza ya utambulisho, yanayopatikana kwenye tovuti ya NHS:
     <ext-link ext-link-type="uri" href="https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/">
      https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/
     </ext-link>
     <sup>
      <xref ref-type="bibr" rid="CR75">
       75
      </xref>
     </sup>
     . Mazoezi ya nguvu yaliyajulikana ni: squats, calf raises, sit-to-stand, leg lifts, leg extensions, wall press ups na bicep curls. Mazoezi haya yanaonekana mara kwa mara kwa wazee, yanaweza kufanyika nyumbani yao, na hawanajulikana kama programu ya mazoezi kubwa. Mawasiliano ya maelezo ya barua pepe walitolewa kwa wiki mara kwa mara wakati wote wa utambulisho ili kujitahidi uaminifu na mazoezi na saketi za viwango.
    </p>
   </sec>
   <sec id="Sec20">
    <title>
     Matokeo
    </title>
    <p id="Par55">
     Matokeo yaliyogundwa kwenye mawasiliano ya utambulisho kwa njia ya video, kwa njia ya kumaliza maongezi kwa mbali, diary ya chakula ya siku tatu kutoa ukurasa wa protini na vifaa vingine vya chakula kusaidia kuelewa tofauti yoyote ya ukurasa ambayo kungaruhusu uchambuzi na battery ya maonyesho ya ujuzi, na kwa njia ya kujipatia vifaa vya kibiashara vya kibiashara kutoka kwa wafanyikazi. Matokeo muhimu ulikuwa tofauti ya muda wa kujifungua kwenye mchapa (muda wa kujifungua mara tano bila kutumia mikono), iliyogundwa kuanza na mwishoni wa utambulisho. Muda wa kujifungua kwenye mchapa ni sehemu ya battery ya matokeo ya uwezo wa kifisadi na ina uhusiano na maisha ya kutosha, uwezo wa kifisadi, uchunguzi, uchovu na, kwa kweli, ujuzi
     <sup>
      <xref ref-type="bibr" rid="CR76">
       76
      </xref>
      ,
      <xref ref-type="bibr" rid="CR77">
       77
      </xref>
     </sup>
     . Ni matokeo inayotolewa kwa uwezo wa kifisadi katika mawasiliano ya European Working Group of Sarcopenia of Older Persons 2
     <sup>
      <xref ref-type="bibr" rid="CR67">
       67
      </xref>
     </sup>
     .
    </p>
    <p id="Par56">
     Matokeo ya mara ya pili ilikuwa anuwai ya battery ya ujuzi, anuwai ya SPPB (inajumuisha muda wa kujifungua kwenye mchapa na mharuko wa mchakato), nguvu ya kujikuta, mharuko wa mchakato, daraja ya uwezo wa kifisadi uliyoruhusiwa kwa wafanyikazi kwa njia ya maongezi ya International Physical Activity Questionnaire (IPAQ) na Simplified Nutritional Assessment Questionnaire (SNAQ) anuwai ya appetiti.
    </p>
   </sec>
   <sec id="Sec21">
    <title>
     Gut microbiome
    </title>
    <p id="Par57">
     Maelezo yote ya usuluhishaji wa gut microbiome yamepatikana kwenye Supplementary Note
     <xref ref-type="supplementary-material" rid="MOESM1">
      1
     </xref>
     <sup/>
     . Kwa jumla, jumla ya 137 DNA aliquots yalitathminiwa kwa ukubwa wa 21.6 million (M) read pairs (Illumina 2 × 150 PE) kwa kila sampuli. Uchambuzi wa mawili ulitengwa, adapters na bases zilitengwa kwa kutrima, na read pairs zilizopita kufiltra kwa ukubwa wa 100 bp au zaidi zilipatikana; zilizohusiana na HQNH reads. 82.8% ya HQNH reads zilipatikana kwenye catalogue ya gene za gut ya Clinical Microbiomics kwa kutumia BWA mem (v. 0.7.17)
     <sup>
      <xref ref-type="bibr" rid="CR78">
       78
      </xref>
     </sup>
     . 326 Metagenomic Species (MGSs) zilipatikana kwa ukurasa wa kila sampuli. Kwa kujumuisha anuwai ya MGS, gene zake zilizotumika kwa kutumia NCBI RefSeq prokaryotic genomes (2022-01-19), na nt (2021-08-03) databases na rank-specific annotation criteria. Rarefied MGS abundance profiles yalitathminiwa kwa kutumia random sampling, bila replacement, ya namba ya gene za signature kwa kila sampuli na kisha kufuata prosesu iliyotolewa hapa juu. Kwenye utambulisho huu, 431127 signature gene counts yalitathminiwa. Usuluhishaji wa anuwai na profiling ya gut microbiome yalitathminiwa kwa kutumia EggNOG mapper (v. 2.0.1), Diamond mode, na KEGG modules (v. 78.2)
     <sup>
      <xref ref-type="bibr" rid="CR79">
       79
      </xref>
      <xref ref-type="bibr" rid="CR80">
       80
      </xref>
     </sup>
     .
    </p>
    <p id="Par58">
     Usuluhishaji zote za gut microbiome zilitumika kwa kutumia relative abundance kwa mazungumzo ya vikundi, wakati anuwai za alpha na beta diversity zilikutathminiwa kutoka kwa rarefied abundance matrices zilizotathminiwa kwa kutumia random sampling bila replacement. Alpha diversity inarejelea uwezo wa kifisadi ndani ya sampuli, wakati anuwai za beta diversity zinarejelea ukurasa wa usimamizi/ukurasa wa sampuli
     <sup>
      <xref ref-type="bibr" rid="CR81">
       81
      </xref>
     </sup>
     . Kwenye kila aina ya data (kisa, MGS), sampuli zote zilipatikana kwa namba sawa ya reads zinazohusiana na sequencing: rarefaction ya anuwai ya MGS iliyotathminiwa kwa kutumia reads zilizopata kwenye gene za signature za MGS, na rarefaction ya anuwai ya Kyoto Encyclopaedia of Genes and Genomes (KEGG) orthology (KO) iliyotathminiwa kwa kutumia reads zilizopata kwenye gene zinazohusiana na KO. Hata hivyo, rarefaction ya anuwai ya gene iliyotathminiwa kwa kutumia reads zilizopata kwenye jumla ya catalogue ya gene. Alpha diversity ilikutathminiwa kama namba ya microorganisms zilizopatikana (richness), kama Shannon index kulingana na logarithm ya asili, au kama Faith’s phylogenetic diversity. Beta diversity ilikutathminiwa kama Bray–Curtis dissimilarity na weighted UniFrac distances.
    </p>
    <p id="Par59">
     Uhusiano kati ya marafiki wanaume ulitathminiwa kwa kutumia uchambuzi wa Mann–Whitney
     <italic>
      U
     </italic>
     na kusababisha na marafiki wanaume sio wanaume, kwa sababu viwango vingi vya ndani na mazingira, kama vile chakula, jiji, aina ya maisha, hali ya kujikomana, na geneti ya mawili yanayeingiza kwa geneti ya mawili
     <sup>
      <xref ref-type="bibr" rid="CR82">
       82
      </xref>
     </sup>
     . Uhusiano wa ukosefu wa geneti ulitathminiwa kwa kutumia model ya ACE kama ilivyoelewe, ili kusaidia kujibu kwa swali kama ukosefu wa geneti wa mikrobiota kati ya marafiki wanaume inaweza kuongezwa kwa ukosefu wa geneti wa mikrobiota
     <sup>
      <xref ref-type="bibr" rid="CR52">
       52
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec22">
    <title>
     Uhitaji wa sampuli
    </title>
    <p id="Par60">
     Kutoka kwenye data iliyopo ndani ya kohort ya TwinsUK, tuliona kuwa muda wa kujifungua kwenye kiti ulikuwa karibu na log-normal, na log10(muda wa kujifungua kwenye kiti) ulikuwa na SD ya 0.126. Tulikubaliwa kuwa tofauti ya 20% katika muda wa kujifungua kwenye kiti ilikuwa ya kuelewa na ya muhimu kliniki. Tulibinafsisha hili kulingana na uchanganuzi wa maalum zilizotumika kwa muda wa kujifungua kwenye kiti, lakini ilionekana kuwa hakuna uchanganuzi uliyotathminiwa hili katika muktadha wa uchanganuzi wa gut microbiome. Kulingana na viwango hivi, tulikuhesabiwa kuwa tutahitaji data kamili kwa 28 wafanyikazi kwa kila kundi (56 mara kwa jumla) kwa nguvu ya 80%. Kukabiliana na wafanyikazi 20% waliozoelekea, tulahitaji
     <italic>
      n
     </italic>
     = 70 wafanyikazi walioingizwa (35 kwa kundi). Kutumia marafiki wanaume inaongeza nguvu ya uchanganuzi kwa sababu ya ukuaji wa karibu kwenye mada ya kuanza, na kuna geneti na au mazingira ya kawaida zinafanya kazi, na kwa hivyo kuna ukawaida zinafanya kazi
     <sup>
      <xref ref-type="bibr" rid="CR35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="CR36">
       36
      </xref>
      ,
      <xref ref-type="bibr" rid="CR37">
       37
      </xref>
      <xref ref-type="bibr" rid="CR83">
       83
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec23">
    <title>
     Uchambuzi wa tiba
    </title>
    <p id="Par61">
     Uchanganuzi ulitathminiwa kwa kutumia Stata SE version 15.1, ingawa uchanganuzi wa gut microbiome ulitathminiwa kwa kutumia R version 4.2.1
     <sup>
      <xref ref-type="bibr" rid="CR84">
       84
      </xref>
      <xref ref-type="bibr" rid="CR85">
       85
      </xref>
     </sup>
     . Kukabiliana na vikundi vya kuchaguliwa viliandikwa tu baada ya kumaliza uchanganuzi wa kumi na kumi wa statistiki. Thamani ya
     <italic>
      P
     </italic>
     ya mara mbili ya &lt;0.05 ilikuwa ya kubaliwa kwa kila uchanganuzi. Wafanyikazi hawakubadilishwa ikiwa walikuwa na data ya mada ya kuanza iliyofokofoka ili kusimamia mada ya uchanganuzi wa intention-to-treat (ITT). Kwa hivyo, kwa data iliyofokofoka katika kategoria hii, teknik za imputation ya mean iliyotumika. Ingawa hivyo, kwa kigeni za kawaida, thamani ya karibuni zaidi kutoka kwenye data ya muda wa kawaida ya TwinsUK iliyotumika ikiwa ilikuwa ya kubaliwa kwa muda ya kawaida. Maamuzi ya imputation ya teknik ziliandaliwa kabla ya kubadilisha maskini.
    </p>
    <p id="Par62">
     Kwa mara ya data ya kawaida iliyofokofoka, kwa mada ya uchanganuzi kuu, ilikuwa kubadilishwa kuwa data iliyofokofoka kwa mara, na athari ya uchanganuzi ilikuwa sawa kwa wale wanao na na wale wanaofokofoka. Hakujulikana kujulikana kwa kawaida ya data iliyofokofoka kwa kila toleo wa uchanganuzi.
    </p>
    <p id="Par63">
     Kuathiri wale waliokataa au walio hawakuwezi kujali, na wale waliokubali, data ya muda wa kawaida ya TwinsUK iliyotumika. T-tests ya mara mbili ya marafiki walitumika kusababisha kila kundi. Toleo la kawaida kati ya kundi mbili kwa jinsia ilibadilishwa kwa umri, na pia, toleo la kawaida kati ya kundi mbili kwa umri ilibadilishwa kwa jinsia ili kuchunguza kama moja ya mawazo haya yanaweza kuongeza toleo kati ya kundi mbili.
    </p>
    <p id="Par64">
     Kuonyesha tofauti zinazohusiana na mikoa ya utafiti kwenye data ya awali, athari zinazohusiana na matumizi ya namba zinatathmini kwa tuzo mbili na athari zinazohusiana na matumizi ya kategoria zinatathmini kwa tuzo ya Pearson’s chi-squared. Tuzo mbili za kawaida zinatathmini matumizi ya data ya chakula kati ya data ya awali na mwisho ya utafiti.
    </p>
    <p id="Par65">
     Kuandaa ujumla wa ufanisi kwa jumla, tuzo la anayafanana la kifaktari zilizotumika kujumuisha matokeo ya tuzo tano za ufanisi (Supplementary Note
     <xref ref-type="supplementary-material" rid="MOESM1">
      2
     </xref>
     ). Tuzo la anayafanana la data ya awali zilizotumika kwa data ya awali na mwisho ya utafiti ili kuhakikisha tuzo zilizosafi. Kifaktari moja kilizotambuliwa kutoka kwenye grafu ya scree kama kilichoingia kwenye tofauti kubwa zaidi. Kwa hiyo, tuzo la anayafanana la data ya awali na mwisho ya utafiti kilizotumika na kizitumika katika tuzo la athari za kawaida. Tuzo la athari za kawaida zilizotumika kusababisha tuzo (mkoa 1 vs mkoa 2; yaliyofichika) kwenye tofauti yao katika kila athari kwa kutumia athari ya kawaida ya athari hiyo kwenye mwisho wa utafiti na kujumlisha athari ya kawaida ya data ya awali katika tuzo. Tuzo ya kawaida ya kizazi kilizotathmini kama athari ya kawaida, kwa ajili ya anayafanana na zygo, na tuzo ya athari ya kawaida ya mkoa kilizotathmini kama athari ya kawaida. Tuzo mbili za kawaida zinatathmini kwa tuzo kati ya data ya awali na mwisho ya utafiti.
    </p>
    <p id="Par66">
     Kuandaa matumizi ya misuli kwa matumizi ya zaidi na chache, tuzo la Goldberg ya matumizi ya namba kwa nisaba ya matumizi ya namba ya kawaida ya matumizi ya namba ya kawaida zinatumika na zinazozidiwa kwa nisaba ya 1.4 ili kuhakikisha matumizi ya namba ya kawaida
     <sup>
      <xref ref-type="bibr" rid="CR86">
       86
      </xref>
      ,
      <xref ref-type="bibr" rid="CR87">
       87
      </xref>
      <xref ref-type="bibr" rid="CR88">
       88
      </xref>
     </sup>
     . Matumizi ya namba ya kawaida ya kazi ya kazi ya ‘light’ ilichaguliwa kulingana na tuzo za IPAQ za wasimamizi kwenye data ya awali.
    </p>
    <p id="Par67">
     Athari za gut microbiota (tuzo, athari, matumizi ya namba, GMMs, na GBMs) zinatathmini kati ya tuzo ya prebiotiki na placebo kwenye data ya awali na mwisho ya utafiti kwa kutumia tuzo la Wilcoxon signed-rank. Pia, tuzo kati ya data ya awali na mwisho ya utafiti zinatathmini kwa kila mkoa kwa kila mkoa. Tulitathmini kama athari zozote za gut microbiota zilizohusiana na athari moja kwa moja ya muda wa kujifungua kwa mchakato kwa data ya awali, mwisho ya utafiti au tofauti kati ya mara hayo. Tofauti ya athari ya gut microbiota iliyotumika kwenye tuzo la uhusiano kati ya tofauti ya muda wa kujifungua na tofauti ya tuzo la ufanisi. Matumizi zote za tofauti ni tofauti kati ya data ya awali na mwisho ya utafiti. Kujenga tofauti za athari za gut microbiota, matumizi ya namba ya namba ya namba zinatumika, na namba za tofauti zinazopatikana zinazobadilishwa kwa tuzo la log ratio na zinatumika kama matumizi ya tuzo la kawaida.
    </p>
    <p id="Par68"/>
   </sec>
   <sec id="Sec24">
    <title>
     Ujumbe kuhusu ulazimisho
    </title>
    <p id="Par69"/>
   </sec>
  </sec>
 </body>
 <back>
  <ack>
   <title>
    Acknowledgements
   </title>
   <p>
    Waziri wanahitaji kusikiliza National Institute of Health Research kwa kusaidia kwenye mafunzo haya. Tunahitaji pia kusikiliza staff ya kuzingatia mafunzo katika Department of Twin Research na wafanyikazi wote. Tunahitaji kusikiliza kwa makusudi Deborah Hart, Ayrun Nessa, Alyce Sheedy, na Gulsah Akdag ambao wamekuwa na mazoezi makubwa kwenye kutoa mafunzo ya PROMOTe. Tunasikiliza TwinsUK Volunteer Advisory Panel kwa mazungumzo na mafadha ili yaliyotoa kuhusu mazungumzo ya mafunzo. Tunahitaji pia kusikiliza Roosa Varjus kwa kusaidia kwenye analysis ya gut microbiome. Mafunzo haya yameingizwa na Kings College London na Guy’s and St Thomas’ NHS Trust. Sponsa wawingi hawakuwa na kigeni katika mazungumzo ya mafunzo, toleo la data na analysis au writing ya manuskrip. Funding MNL inasaidia kwa NIHR Doctoral Fellowship (grant code: NIHR300159). C.J.S. anapewa funds kutoka kwa Medical Research Council (MRC), Wellcome Trust (grant code WT 212904/Z/18/Z), na Chronic Disease Research Foundation. K.W. amepewa funds kutoka kwa MRC, NIHR, Crohn’s and Colitis UK, Kenneth Rainin Foundation, Leona M. and Harry B. Helmsley Charitable Trust, Almond Board of California, Danone, na International Dried Fruit Council. TwinsUK inapewa funds kutoka kwa Wellcome Trust, Wellcome LEAP, Medical Research Council, Versus Arthritis, Engineering &amp; Physical Sciences Research Council, Biotechnology and Biological Sciences Research Council, European Commission, Chronic Disease Research Foundation (CDRF), Zoe Ltd., National Institute for Health and Care Research (NIHR) Clinical Research Network (CRN) na Biomedical Research Centre ambayo inauminiwa na Guy’s and St Thomas’ NHS Foundation Trust na King’s College London. myfood24 dietary reporting software iliyotumika katika mafunzo haya. myfood24 iliyotengenezwa kwa kutumia Medical Research Council funding, grant G110235. myfood24 inaingizwa kwa spinout company Dietary Assessment Ltd. Mafungo ya kutumia myfood24 yanapaswa kufanyika kwa enquiries@myfood24.org.
   </p>
  </ack>
  <sec sec-type="author-contribution">
   <title>
    Author contributions
   </title>
   <p>
    M.N.L., K.W. na C.J.S. walizungumza mafunzo na kandaa protocol kwa kusaidia kutoka kwa R.C.E.B., M.P.G, S.W., A.F.B, A.N., A.S., G.A., D.H., C.M., S.D.R.H., A.A.W. na C.G., A.N., A.S., G.A., D.H. na C.M. walisaidia mafunzo ya kliniki, kulingana na recruitment na/au management ya wafanyikazi katika mafunzo. M.N.L. alifanya analysis ya statistical kwa kusaidia kutoka kwa C.J.S, K.W. R.C.E.B, P.T.S. na G.R. J.M.M. alifanya analysis ya gut microbiome kwa kusaidia kutoka kwa M.N.L., C.J.S. na R.C.E.B. M.N.L., S.W., A.F.B, A.N. na A.S. walisaidia kusimulia data na samples. M.N.L. alikandaa manuskrip. Waziri wote wameangalia manuskrip na kusaidia kwenye toleo la mwisho.
   </p>
  </sec>
  <sec sec-type="peer-review">
   <title>
    Uwajibikiano wa watafsiri
   </title>
   <sec id="FPar1">
    <title>
     Uwajibikiano wa data
    </title>
    <p id="Par70">
     <italic>
      Nature Communications
     </italic>
     thanks Edward Chambers, Ali Keshavarzian and Huang Lin for their contribution to the peer review of this work. A peer review file is available.
    </p>
   </sec>
  </sec>
  <sec sec-type="data-availability">
   <title>
    Uwajibikiano wa programu
   </title>
   <p>
    The gut microbiome sequencing data generated in this study have been deposited in the European Nucleotide Archive (ENA) at EMBL-EBI under accession number
    <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/browser/view/PRJEB72531">
     PRJEB72531
    </ext-link>
    . All other data are available on request from TwinsUK, and access can be obtained after approval by the TwinsUK Resource Executive Committee by following this link:
    <ext-link ext-link-type="uri" xlink:href="https://twinsuk.ac.uk/resources-for-researchers/access-our-data/">
     https://twinsuk.ac.uk/resources-for-researchers/access-our-data/
    </ext-link>
    .
   </p>
  </sec>
  <sec sec-type="data-availability">
   <title>
    Uwajibikiano wa matendo ya kizazi
   </title>
   <p>
    Stata code was utilised for data cleaning and analysis using Stata SE version 15.1
    <sup>
     <xref ref-type="bibr" rid="CR84">
      84
     </xref>
    </sup>
    . Gut microbiome analysis utilised R version 4.2.1
    <sup>
     <xref ref-type="bibr" rid="CR85">
      85
     </xref>
    </sup>
    , using R packages vegan (available from:
    <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/vegan/index.html">
     https://cran.r-project.org/web/packages/vegan/index.html
    </ext-link>
    ) and Mets (available from
    <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/mets/index.html">
     https://cran.r-project.org/web/packages/mets/index.html
    </ext-link>
    ).
   </p>
  </sec>
  <sec sec-type="ethics-statement">
   <sec id="FPar2" sec-type="COI-statement">
    <title>
     Uwajibikiano wa kihakika
    </title>
    <p id="Par71">
     C.J.S. has consulted for Zoe Limited for work on the Zoe Health Study. Janne Marie Moll is an employee of Clinical Microbiomics. K.W. is a co-inventor/patent holder for volatile organic compounds in the diagnosis and management of irritable bowel syndrome. The remaining authors declare no competing interests.
    </p>
   </sec>
   <sec id="FPar3">
    <title>
     Uwajibikiano wa viungo
    </title>
    <p id="Par72">
     The PROMOTe Study was approved by NHS North of Scotland Research Ethics Service (REC reference 21/NS/0045), IRAS ID 257415. This study was carried out under TwinsUK BioBank ethics, approved by North West—Liverpool Central Research Ethics Committee (REC reference 19/NW/0187), IRAS ID 258513. This approval supersedes earlier approvals granted to TwinsUK by the St Thomas’ Hospital Research Ethics Committee, later London—Westminster Research Ethics Committee (REC reference EC04/015), which have now been subsumed within the TwinsUK BioBank. Written informed consent was obtained from all participants. All research, therefore carried out in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
    </p>
   </sec>
  </sec>
  <ref-list id="Bib1">
   <title>
    Uwajibikiano wa taarifa zazifuatazo
   </title>
   <ref-list>
    <ref id="CR1">
     <label>
      1.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kingston
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Is late-life dependency increasing or not? A comparison of the Cognitive Function and Ageing Studies (CFAS)
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       2017
      </year>
      <volume>
       390
      </volume>
      <fpage>
       1676
      </fpage>
      <lpage>
       1684
      </lpage>
      <pub-id pub-id-type="pmid">
       28821408
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5640505
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(17)31575-1
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR2">
     <label>
      2.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Arvanitakis
        </surname>
        <given-names>
         Z
        </given-names>
       </name>
       <name>
        <surname>
         Shah
        </surname>
        <given-names>
         RC
        </given-names>
       </name>
       <name>
        <surname>
         Bennett
        </surname>
        <given-names>
         DA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Diagnosis and management of dementia: review
      </article-title>
      <source>
       J. Am. Med. Assoc.
      </source>
      <year>
       2019
      </year>
      <volume>
       322
      </volume>
      <fpage>
       1589
      </fpage>
      <pub-id pub-id-type="doi">
       10.1001/jama.2019.4782
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR3">
     <label>
      3.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Harada
        </surname>
        <given-names>
         CN
        </given-names>
       </name>
       <name>
        <surname>
         Natelson Love
        </surname>
        <given-names>
         MC
        </given-names>
       </name>
       <name>
        <surname>
         Triebel
        </surname>
        <given-names>
         KL
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Normal cognitive aging
      </article-title>
      <source>
       Clin. Geriatr. Med.
      </source>
      <year>
       2013
      </year>
      <volume>
       29
      </volume>
      <fpage>
       737
      </fpage>
      <lpage>
       752
      </lpage>
      <pub-id pub-id-type="pmid">
       24094294
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4015335
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cger.2013.07.002
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR4">
     <label>
      4.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sayer
        </surname>
        <given-names>
         AA
        </given-names>
       </name>
       <name>
        <surname>
         Cruz-Jentoft
        </surname>
        <given-names>
         A
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Sarcopenia definition, diagnosis and treatment: consensus is growing
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2022
      </year>
      <volume>
       51
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       5
      </lpage>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afac220
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR5">
     <label>
      5.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mandolesi
        </surname>
        <given-names>
         L
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effects of physical exercise on cognitive functioning and wellbeing: biological and psychological benefits
      </article-title>
      <source>
       Front. Psychol.
      </source>
      <year>
       2018
      </year>
      <volume>
       9
      </volume>
      <fpage>
       509
      </fpage>
      <pub-id pub-id-type="pmid">
       29755380
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5934999
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fpsyg.2018.00509
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR6">
     <label>
      6.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Bowyer
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Steves
        </surname>
        <given-names>
         C
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Dietary protein and muscle in aging people: the potential role of the gut microbiome
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2018
      </year>
      <volume>
       10
      </volume>
      <fpage>
       929
      </fpage>
      <pub-id pub-id-type="pmid">
       30036990
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6073774
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu10070929
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR7">
     <label>
      7.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Welch
        </surname>
        <given-names>
         AA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Nutritional influences on age-related skeletal muscle loss
      </article-title>
      <source>
       Proc. Nutr. Soc.
      </source>
      <year>
       2014
      </year>
      <volume>
       73
      </volume>
      <fpage>
       16
      </fpage>
      <lpage>
       33
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXitFylsL4%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24229650
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S0029665113003698
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR8">
     <label>
      8.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Deutz
        </surname>
        <given-names>
         NEP
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group
      </article-title>
      <source>
       Clin. Nutr.
      </source>
      <year>
       2014
      </year>
      <volume>
       33
      </volume>
      <fpage>
       929
      </fpage>
      <lpage>
       936
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXnslehtL0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24814383
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4208946
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.clnu.2014.04.007
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR9">
     <label>
      9.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cermak
        </surname>
        <given-names>
         NM
        </given-names>
       </name>
       <name>
        <surname>
         Res
        </surname>
        <given-names>
         PT
        </given-names>
       </name>
       <name>
        <surname>
         de Groot
        </surname>
        <given-names>
         LC
        </given-names>
       </name>
       <name>
        <surname>
         Saris
        </surname>
        <given-names>
         WHM
        </given-names>
       </name>
       <name>
        <surname>
         van Loon
        </surname>
        <given-names>
         LJ
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2012
      </year>
      <volume>
       96
      </volume>
      <fpage>
       1454
      </fpage>
      <lpage>
       1464
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38XhslylsbfF
      </pub-id>
      <pub-id pub-id-type="pmid">
       23134885
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.112.037556
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR10">
     <label>
      10.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Daly
        </surname>
        <given-names>
         RM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Does lean red meat enhance the effetcs of exercise on muscle health and function in the elderly?
       <italic>
        Innov
       </italic>
      </article-title>
      <source>
       Aging
      </source>
      <year>
       2017
      </year>
      <volume>
       1
      </volume>
      <fpage>
       3
      </fpage>
      <lpage>
       4
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR11">
     <label>
      11.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Daly
        </surname>
        <given-names>
         RM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Protein-enriched diet, with the use of lean red meat, combined with progressive resistance training enhances lean tissue mass and muscle strength and reduces circulating IL-6 concentrations in elderly women: a cluster randomized controlled trial
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2014
      </year>
      <volume>
       99
      </volume>
      <fpage>
       899
      </fpage>
      <lpage>
       910
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXls1Oiur0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24477043
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.113.064154
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR12">
     <label>
      12.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Marchesi
        </surname>
        <given-names>
         JR
        </given-names>
       </name>
       <name>
        <surname>
         Ravel
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The vocabulary of microbiome research: a proposal
      </article-title>
      <source>
       Microbiome
      </source>
      <year>
       2015
      </year>
      <volume>
       3
      </volume>
      <pub-id pub-id-type="pmid">
       26229597
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4520061
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s40168-015-0094-5
      </pub-id>
      <elocation-id>
       31
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR13">
     <label>
      13.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Biagi
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2010
      </year>
      <volume>
       5
      </volume>
      <fpage>
       e10667
      </fpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2010PLoSO...510667B
      </pub-id>
      <pub-id pub-id-type="pmid">
       20498852
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2871786
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0010667
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR14">
     <label>
      14.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Grosicki
        </surname>
        <given-names>
         GJ
        </given-names>
       </name>
       <name>
        <surname>
         Fielding
        </surname>
        <given-names>
         RA
        </given-names>
       </name>
       <name>
        <surname>
         Lustgarten
        </surname>
        <given-names>
         MS
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota contribute to age-related changes in skeletal muscle size, composition, and function: biological basis for a gut-muscle axis
      </article-title>
      <source>
       Calcif. Tissue Int.
      </source>
      <year>
       2018
      </year>
      <volume>
       102
      </volume>
      <fpage>
       433
      </fpage>
      <lpage>
       442
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhslWjurrJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       29058056
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00223-017-0345-5
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR15">
     <label>
      15.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ticinesi
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: is there a gut-muscle axis?
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2017
      </year>
      <volume>
       9
      </volume>
      <fpage>
       1303
      </fpage>
      <pub-id pub-id-type="pmid">
       29189738
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5748753
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu9121303
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR16">
     <label>
      16.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ticinesi
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients
      </article-title>
      <source>
       Sci. Rep.
      </source>
      <year>
       2017
      </year>
      <volume>
       7
      </volume>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2017NatSR...711102T
      </pub-id>
      <pub-id pub-id-type="pmid">
       28894183
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5593887
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41598-017-10734-y
      </pub-id>
      <elocation-id>
       11102
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR17">
     <label>
      17.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ridaura
        </surname>
        <given-names>
         VK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota from twins discordant for obesity modulate metabolism in mice
      </article-title>
      <source>
       Science (1979)
      </source>
      <year>
       2013
      </year>
      <volume>
       341
      </volume>
      <fpage>
       1241214
      </fpage>
     </mixed-citation>
    </ref>
    <ref id="CR18">
     <label>
      18.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Prokopidis
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <name>
        <surname>
         Chambers
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Witard
        </surname>
        <given-names>
         OC
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mechanisms linking the gut-muscle axis with muscle protein metabolism and anabolic resistance: implications for older adults at risk of sarcopenia
      </article-title>
      <source>
       Front. Physiol.
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       1910
      </fpage>
      <pub-id pub-id-type="doi">
       10.3389/fphys.2021.770455
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR19">
     <label>
      19.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Raj
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Dileep
        </surname>
        <given-names>
         U
        </given-names>
       </name>
       <name>
        <surname>
         Vaz
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Fuller
        </surname>
        <given-names>
         MF
        </given-names>
       </name>
       <name>
        <surname>
         Kurpad
        </surname>
        <given-names>
         AV
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Intestinal microbial contribution to metabolic leucine input in adult men
      </article-title>
      <source>
       J. Nutr.
      </source>
      <year>
       2008
      </year>
      <volume>
       138
      </volume>
      <fpage>
       2217
      </fpage>
      <lpage>
       2221
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1cXht1ymtr7J
      </pub-id>
      <pub-id pub-id-type="pmid">
       18936222
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/jn.108.093021
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR20">
     <label>
      20.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zhang
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Cheng
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <name>
        <surname>
         Hu
        </surname>
        <given-names>
         YM
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota as a promising therapeutic target for age-related sarcopenia
      </article-title>
      <source>
       Ageing Res. Rev.
      </source>
      <year>
       2022
      </year>
      <volume>
       81
      </volume>
      <fpage>
       101739
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38Xis1aisr%2FN
      </pub-id>
      <pub-id pub-id-type="pmid">
       36182084
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.arr.2022.101739
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR21">
     <label>
      21.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         de Marco Castro
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Murphy
        </surname>
        <given-names>
         CH
        </given-names>
       </name>
       <name>
        <surname>
         Roche
        </surname>
        <given-names>
         HM
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Targeting the gut microbiota to improve dietary protein efficacy to mitigate sarcopenia
      </article-title>
      <source>
       Front. Nutr.
      </source>
      <year>
       2021
      </year>
      <volume>
       8
      </volume>
      <fpage>
       656730
      </fpage>
      <pub-id pub-id-type="pmid">
       34235167
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8256992
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fnut.2021.656730
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR22">
     <label>
      22.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lahiri
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The gut microbiota influences skeletal muscle mass and function in mice
      </article-title>
      <source>
       Sci. Transl. Med.
      </source>
      <year>
       2019
      </year>
      <volume>
       11
      </volume>
      <fpage>
       eaan5662
      </fpage>
      <pub-id pub-id-type="pmid">
       31341063
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7501733
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1126/scitranslmed.aan5662
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR23">
     <label>
      23.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Manickam
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Oh
        </surname>
        <given-names>
         HYP
        </given-names>
       </name>
       <name>
        <surname>
         Tan
        </surname>
        <given-names>
         CK
        </given-names>
       </name>
       <name>
        <surname>
         Paramalingam
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Wahli
        </surname>
        <given-names>
         W
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Metronidazole causes skeletal muscle atrophy and modulates muscle chronometabolism
      </article-title>
      <source>
       Int. J. Mol. Sci.
      </source>
      <year>
       2018
      </year>
      <volume>
       19
      </volume>
      <fpage>
       2418
      </fpage>
      <pub-id pub-id-type="pmid">
       30115857
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6121908
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/ijms19082418
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR24">
     <label>
      24.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         GR
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The International Scientific Association for Probiotics and Prebiotics (ISAPP) Consensus statement on the definition and scope of prebiotics
      </article-title>
      <source>
       Nat. Rev. Gastroenterol. Hepatol.
      </source>
      <year>
       2017
      </year>
      <volume>
       14
      </volume>
      <fpage>
       491
      </fpage>
      <lpage>
       502
      </lpage>
      <pub-id pub-id-type="pmid">
       28611480
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nrgastro.2017.75
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR25">
     <label>
      25.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Buigues
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effect of a prebiotic formulation on frailty syndrome: a randomized, double-blind clinical trial
      </article-title>
      <source>
       Int. J. Mol. Sci.
      </source>
      <year>
       2016
      </year>
      <volume>
       17
      </volume>
      <fpage>
       932
      </fpage>
      <pub-id pub-id-type="pmid">
       27314331
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4926465
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/ijms17060932
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR26">
     <label>
      26.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Theou
        </surname>
        <given-names>
         O
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Can a prebiotic formulation reduce frailty levels in older people?
      </article-title>
      <source>
       J. Frailty Aging
      </source>
      <year>
       2018
      </year>
      <volume>
       8
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       5
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR27">
     <label>
      27.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Desmedt
        </surname>
        <given-names>
         O
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effects of prebiotics on affect and cognition in human intervention studies
      </article-title>
      <source>
       Nutr. Rev.
      </source>
      <year>
       2019
      </year>
      <volume>
       77
      </volume>
      <fpage>
       81
      </fpage>
      <lpage>
       95
      </lpage>
      <pub-id pub-id-type="pmid">
       30535275
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/nutrit/nuy052
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR28">
     <label>
      28.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cox
        </surname>
        <given-names>
         NJ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The composition of the gut microbiome differs among community dwelling older people with good and poor appetite
      </article-title>
      <source>
       J. Cachexia Sarcopenia Muscle
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       368
      </fpage>
      <lpage>
       377
      </lpage>
      <pub-id pub-id-type="pmid">
       33580637
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8061352
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/jcsm.12683
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR29">
     <label>
      29.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Guess
        </surname>
        <given-names>
         ND
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A randomized controlled trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes
      </article-title>
      <source>
       Nutr. Metab. (Lond.)
      </source>
      <year>
       2015
      </year>
      <volume>
       12
      </volume>
      <fpage>
       36
      </fpage>
      <pub-id pub-id-type="pmid">
       26500686
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12986-015-0033-2
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR30">
     <label>
      30.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Liber
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Szajewska
        </surname>
        <given-names>
         H
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Effects of inulin-type fructans on appetite, energy intake, and body weight in children and adults: systematic review of randomized controlled trials
      </article-title>
      <source>
       Ann. Nutr. Metab.
      </source>
      <year>
       2013
      </year>
      <volume>
       63
      </volume>
      <fpage>
       42
      </fpage>
      <lpage>
       54
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhsF2rsL7L
      </pub-id>
      <pub-id pub-id-type="pmid">
       23887189
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1159/000350312
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR31">
     <label>
      31.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Baker
        </surname>
        <given-names>
         JE
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Visual paired associate learning deficits associated with elevated beta-amyloid in cognitively normal older adults
      </article-title>
      <source>
       Neuropsychology
      </source>
      <year>
       2019
      </year>
      <volume>
       33
      </volume>
      <fpage>
       964
      </fpage>
      <lpage>
       974
      </lpage>
      <pub-id pub-id-type="pmid">
       31368758
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1037/neu0000561
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR32">
     <label>
      32.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Hicks
        </surname>
        <given-names>
         EB
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Associations of visual paired associative learning task with global cognition and its potential usefulness as a screening tool for Alzheimer’s Dementia
      </article-title>
      <source>
       Int. Psychogeriatr.
      </source>
      <year>
       2021
      </year>
      <volume>
       33
      </volume>
      <fpage>
       1135
      </fpage>
      <lpage>
       1144
      </lpage>
      <pub-id pub-id-type="pmid">
       33336635
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S1041610220003841
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR33">
     <label>
      33.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Vulevic
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Drakoularakou
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Yaqoob
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Tzortzis
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         GR
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2008
      </year>
      <volume>
       88
      </volume>
      <fpage>
       1438
      </fpage>
      <lpage>
       1484
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1cXhtlOqu7vP
      </pub-id>
      <pub-id pub-id-type="pmid">
       18996881
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.2008.26242
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR34">
     <label>
      34.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Bergquist
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Performance-based clinical tests of balance and muscle strength used in young seniors: a systematic literature review
      </article-title>
      <source>
       BMC Geriatr.
      </source>
      <year>
       2019
      </year>
      <volume>
       19
      </volume>
      <fpage>
       9
      </fpage>
      <pub-id pub-id-type="pmid">
       30626340
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6327480
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12877-018-1011-0
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR35">
     <label>
      35.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Harvey
        </surname>
        <given-names>
         NC
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Measures of physical performance and muscle strength as predictors of fracture risk independent of FRAX, Falls, and aBMD: a meta-analysis of the osteoporotic fractures in men (MrOS) study
      </article-title>
      <source>
       J. Bone Miner. Res.
      </source>
      <year>
       2018
      </year>
      <volume>
       33
      </volume>
      <fpage>
       2150
      </fpage>
      <lpage>
       2157
      </lpage>
      <pub-id pub-id-type="pmid">
       30011086
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/jbmr.3556
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR36">
     <label>
      36.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Walker
        </surname>
        <given-names>
         SN
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Maintenance of activity and eating change after a clinical trial of tailored newsletters with older rural women
      </article-title>
      <source>
       Nurs. Res.
      </source>
      <year>
       2010
      </year>
      <volume>
       59
      </volume>
      <fpage>
       311
      </fpage>
      <lpage>
       321
      </lpage>
      <pub-id pub-id-type="pmid">
       20697307
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2963620
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1097/NNR.0b013e3181ed6695
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR37">
     <label>
      37.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cesari
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Added value of physical performance measures in predicting adverse health-related events: results from the health, aging, and body composition study
      </article-title>
      <source>
       J. Am. Geriatr. Soc.
      </source>
      <year>
       2009
      </year>
      <volume>
       57
      </volume>
      <fpage>
       251
      </fpage>
      <lpage>
       259
      </lpage>
      <pub-id pub-id-type="pmid">
       19207142
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2695653
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/j.1532-5415.2008.02126.x
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR38">
     <label>
      38.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tandon
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora
      </article-title>
      <source>
       Sci. Rep.
      </source>
      <year>
       2019
      </year>
      <volume>
       9
      </volume>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2019NatSR...9.5473T
      </pub-id>
      <pub-id pub-id-type="pmid">
       30940833
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6445088
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41598-019-41837-3
      </pub-id>
      <elocation-id>
       5473
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR39">
     <label>
      39.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         So
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2018
      </year>
      <volume>
       107
      </volume>
      <fpage>
       965
      </fpage>
      <lpage>
       983
      </lpage>
      <pub-id pub-id-type="pmid">
       29757343
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ajcn/nqy041
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR40">
     <label>
      40.
     </label>
     <mixed-citation publication-type="other">
      Cognitive Tests | Cambridge Cognition.
      <ext-link ext-link-type="uri" xlink:href="https://www.cambridgecognition.com/cantab/cognitive-tests/">
       https://www.cambridgecognition.com/cantab/cognitive-tests/
      </ext-link>
      .
     </mixed-citation>
    </ref>
    <ref id="CR41">
     <label>
      41.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cryan
        </surname>
        <given-names>
         JF
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The microbiota-gut-brain axis
      </article-title>
      <source>
       Physiol. Rev.
      </source>
      <year>
       2019
      </year>
      <volume>
       99
      </volume>
      <fpage>
       1877
      </fpage>
      <lpage>
       2013
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXitFWjsLs%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       31460832
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1152/physrev.00018.2018
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR42">
     <label>
      42.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Jenkins
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Nguyen
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Polglaze
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <name>
        <surname>
         Bertrand
        </surname>
        <given-names>
         P
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2016
      </year>
      <volume>
       8
      </volume>
      <fpage>
       56
      </fpage>
      <pub-id pub-id-type="pmid">
       26805875
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4728667
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu8010056
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR43">
     <label>
      43.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Grenham
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Clarke
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Cryan
        </surname>
        <given-names>
         JF
        </given-names>
       </name>
       <name>
        <surname>
         Dinan
        </surname>
        <given-names>
         TG
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Brain-gut-microbe communication in health and disease
      </article-title>
      <source>
       Front. Physiol.
      </source>
      <year>
       2011
      </year>
      <volume>
       2
      </volume>
      <fpage>
       94
      </fpage>
      <pub-id pub-id-type="pmid">
       22162969
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3232439
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fphys.2011.00094
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR44">
     <label>
      44.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gaman
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Kuo
        </surname>
        <given-names>
         B
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Neuromodulatory processes of the brain–gut axis
      </article-title>
      <source>
       Neuromodulation
      </source>
      <year>
       2008
      </year>
      <volume>
       11
      </volume>
      <fpage>
       249
      </fpage>
      <lpage>
       259
      </lpage>
      <pub-id pub-id-type="pmid">
       19844605
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2763396
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/j.1525-1403.2008.00172.x
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR45">
     <label>
      45.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tran
        </surname>
        <given-names>
         TTT
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Prebiotic supplementation in frail older people affects specific gut microbiota taxa but not global diversity
      </article-title>
      <source>
       Microbiome
      </source>
      <year>
       2019
      </year>
      <volume>
       7
      </volume>
      <pub-id pub-id-type="pmid">
       30867067
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6417215
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s40168-019-0654-1
      </pub-id>
      <elocation-id>
       39
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR46">
     <label>
      46.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lancaster
        </surname>
        <given-names>
         SM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Global, distinctive, and personal changes in molecular and microbial profiles by specific fibers in humans
      </article-title>
      <source>
       Cell Host Microbe
      </source>
      <year>
       2022
      </year>
      <volume>
       30
      </volume>
      <fpage>
       848
      </fpage>
      <lpage>
       862.e7
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XhtFejtbvE
      </pub-id>
      <pub-id pub-id-type="pmid">
       35483363
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9187607
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.chom.2022.03.036
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR47">
     <label>
      47.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Healey
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study
      </article-title>
      <source>
       Br. J. Nutr.
      </source>
      <year>
       2018
      </year>
      <volume>
       119
      </volume>
      <fpage>
       176
      </fpage>
      <lpage>
       189
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXhsVarsrg%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       29307330
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S0007114517003440
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR48">
     <label>
      48.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Le Bastard
        </surname>
        <given-names>
         Q
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The effects of inulin on gut microbial composition: a systematic review of evidence from human studies
      </article-title>
      <source>
       Eur. J. Clin. Microbiol. Infect. Dis.
      </source>
      <year>
       2020
      </year>
      <volume>
       39
      </volume>
      <fpage>
       403
      </fpage>
      <lpage>
       413
      </lpage>
      <pub-id pub-id-type="pmid">
       31707507
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s10096-019-03721-w
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR49">
     <label>
      49.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Watson
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Selective carbohydrate utilization by lactobacilli and bifidobacteria
      </article-title>
      <source>
       J. Appl. Microbiol.
      </source>
      <year>
       2013
      </year>
      <volume>
       114
      </volume>
      <fpage>
       1132
      </fpage>
      <lpage>
       1146
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXkt1Kiu7o%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       23240984
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/jam.12105
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR50">
     <label>
      50.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wilson
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <name>
        <surname>
         Rossi
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Dimidi
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Whelan
        </surname>
        <given-names>
         K
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2019
      </year>
      <volume>
       109
      </volume>
      <fpage>
       1098
      </fpage>
      <lpage>
       1111
      </lpage>
      <pub-id pub-id-type="pmid">
       30949662
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ajcn/nqy376
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR51">
     <label>
      51.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cherbut
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Michel
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Lecannu
        </surname>
        <given-names>
         G
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats
      </article-title>
      <source>
       J. Nutr.
      </source>
      <year>
       2003
      </year>
      <volume>
       133
      </volume>
      <fpage>
       21
      </fpage>
      <lpage>
       27
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD3sXjslejtg%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       12514261
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/jn/133.1.21
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR52">
     <label>
      52.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodrich
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Genetic determinants of the gut microbiome in UK twins
      </article-title>
      <source>
       Cell Host Microbe
      </source>
      <year>
       2016
      </year>
      <volume>
       19
      </volume>
      <fpage>
       731
      </fpage>
      <lpage>
       743
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XntlShtbo%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27173935
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4915943
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.chom.2016.04.017
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR53">
     <label>
      53.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodrich
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Human genetics shape the gut microbiome
      </article-title>
      <source>
       Cell
      </source>
      <year>
       2014
      </year>
      <volume>
       159
      </volume>
      <fpage>
       789
      </fpage>
      <lpage>
       799
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhvV2msrnJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       25417156
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4255478
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cell.2014.09.053
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR54">
     <label>
      54.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Yang
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Unfavourable intrauterine environment contributes to abnormal gut microbiome and metabolome in twins
      </article-title>
      <source>
       Gut
      </source>
      <year>
       2022
      </year>
      <volume>
       71
      </volume>
      <fpage>
       2451
      </fpage>
      <lpage>
       2462
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XivFegtb3P
      </pub-id>
      <pub-id pub-id-type="pmid">
       35387876
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1136/gutjnl-2021-326482
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR55">
     <label>
      55.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Xie
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Shotgun metagenomics of 250 adult twins reveals genetic and environmental impacts on the gut microbiome
      </article-title>
      <source>
       Cell Syst.
      </source>
      <year>
       2016
      </year>
      <volume>
       3
      </volume>
      <fpage>
       572
      </fpage>
      <lpage>
       584.e3
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhtFalsLw%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27818083
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6309625
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cels.2016.10.004
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR56">
     <label>
      56.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Stincone
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
      </article-title>
      <source>
       Biol. Rev.
      </source>
      <year>
       2015
      </year>
      <volume>
       90
      </volume>
      <fpage>
       927
      </fpage>
      <lpage>
       963
      </lpage>
      <pub-id pub-id-type="pmid">
       25243985
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/brv.12140
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR57">
     <label>
      57.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wagner
        </surname>
        <given-names>
         KR
        </given-names>
       </name>
       <name>
        <surname>
         Kauffman
        </surname>
        <given-names>
         FC
        </given-names>
       </name>
       <name>
        <surname>
         Max
        </surname>
        <given-names>
         SR
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The pentose phosphate pathway in regenerating skeletal muscle
      </article-title>
      <source>
       Biochem. J.
      </source>
      <year>
       1978
      </year>
      <volume>
       170
      </volume>
      <fpage>
       17
      </fpage>
      <lpage>
       22
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DyaE1cXhsV2ks7Y%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       629775
      </pub-id>
      <pub-id pub-id-type="pmcid">
       1183856
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1042/bj1700017
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR58">
     <label>
      58.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Valentino
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Figueiredo
        </surname>
        <given-names>
         VC
        </given-names>
       </name>
       <name>
        <surname>
         Mobley
        </surname>
        <given-names>
         CB
        </given-names>
       </name>
       <name>
        <surname>
         McCarthy
        </surname>
        <given-names>
         JJ
        </given-names>
       </name>
       <name>
        <surname>
         Vechetti
        </surname>
        <given-names>
         IJ
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Evidence of myomiR regulation of the pentose phosphate pathway during mechanical load‐induced hypertrophy
      </article-title>
      <source>
       Physiol. Rep.
      </source>
      <year>
       2021
      </year>
      <volume>
       9
      </volume>
      <fpage>
       15137
      </fpage>
      <pub-id pub-id-type="doi">
       10.14814/phy2.15137
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR59">
     <label>
      59.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Carabotti
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Scirocco
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Maselli
        </surname>
        <given-names>
         MA
        </given-names>
       </name>
       <name>
        <surname>
         Severi
        </surname>
        <given-names>
         C
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems
      </article-title>
      <source>
       Ann. Gastroenterol.
      </source>
      <year>
       2015
      </year>
      <volume>
       28
      </volume>
      <fpage>
       203
      </fpage>
      <pub-id pub-id-type="pmid">
       25830558
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4367209
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR60">
     <label>
      60.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Connell
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
      </article-title>
      <source>
       Mol. Neurodegener.
      </source>
      <year>
       2022
      </year>
      <volume>
       17
      </volume>
      <fpage>
       43
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XitVeqt7bF
      </pub-id>
      <pub-id pub-id-type="pmid">
       35715821
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9204954
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13024-022-00548-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR61">
     <label>
      61.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Jeong
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Cognitive function associated with gut microbial abundance in sucrose and S-adenosyl-L-methionine (SAMe) metabolic pathways
      </article-title>
      <source>
       J. Alzheimer’s Dis.
      </source>
      <year>
       2022
      </year>
      <volume>
       87
      </volume>
      <fpage>
       1115
      </fpage>
      <lpage>
       1130
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38Xhtl2lurvK
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3233/JAD-215090
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR62">
     <label>
      62.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         Z
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Altered actinobacteria and firmicutes phylum associated epitopes in patients with Parkinson’s disease
      </article-title>
      <source>
       Front. Immunol.
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       2541
      </fpage>
     </mixed-citation>
    </ref>
    <ref id="CR63">
     <label>
      63.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Fernandez-Real
        </surname>
        <given-names>
         J-M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota interacts with brain microstructure and function
      </article-title>
      <source>
       J. Clin. Endocrinol. Metab.
      </source>
      <year>
       2015
      </year>
      <volume>
       100
      </volume>
      <fpage>
       4505
      </fpage>
      <lpage>
       4513
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XjtlSntr0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       26445114
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1210/jc.2015-3076
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR64">
     <label>
      64.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tooley
        </surname>
        <given-names>
         KL
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Effects of the human gut microbiota on cognitive performance, brain structure and function: a narrative review
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2020
      </year>
      <volume>
       12
      </volume>
      <fpage>
       3009
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXitlyjur3K
      </pub-id>
      <pub-id pub-id-type="pmid">
       33007941
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7601389
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu12103009
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR65">
     <label>
      65.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Witham
        </surname>
        <given-names>
         MD
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process
      </article-title>
      <source>
       Trials
      </source>
      <year>
       2020
      </year>
      <volume>
       21
      </volume>
      <pub-id pub-id-type="pmid">
       32738919
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7395975
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13063-020-04613-7
      </pub-id>
      <elocation-id>
       694
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR66">
     <label>
      66.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodwin
        </surname>
        <given-names>
         VA
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       INCLUDE older people: best practice recommendations in health and social care research
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2023
      </year>
      <volume>
       52
      </volume>
      <fpage>
       afad082
      </fpage>
      <pub-id pub-id-type="pmid">
       37261448
      </pub-id>
      <pub-id pub-id-type="pmcid">
       10234283
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afad082
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR67">
     <label>
      67.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cruz-Jentoft
        </surname>
        <given-names>
         AJ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Sarcopenia: revised European consensus on definition and diagnosis
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2019
      </year>
      <volume>
       48
      </volume>
      <fpage>
       601
      </fpage>
      <lpage>
       601
      </lpage>
      <pub-id pub-id-type="pmid">
       31081853
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6593317
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afz046
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR68">
     <label>
      68.
     </label>
     <mixed-citation publication-type="other">
      Verdi, S. et al. TwinsUK: The UK Adult Twin Registry Update.
      <italic>
       Twin Res. Hum. Genetics
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.1017/thg.2019.65">
       https://doi.org/10.1017/thg.2019.65
      </ext-link>
      (2019).
     </mixed-citation>
    </ref>
    <ref id="CR69">
     <label>
      69.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The PROMOTe study: targeting the gut microbiome with prebiotics to overcome age-related anabolic resistance: protocol for a double-blinded, randomised, placebo-controlled trial
      </article-title>
      <source>
       BMC Geriatr.
      </source>
      <year>
       2021
      </year>
      <volume>
       21
      </volume>
      <fpage>
       407
      </fpage>
      <pub-id pub-id-type="pmid">
       34210274
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8248289
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12877-021-02301-y
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR70">
     <label>
      70.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Masoli
        </surname>
        <given-names>
         JAH
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyond
      </article-title>
      <source>
       Trials
      </source>
      <year>
       2021
      </year>
      <volume>
       22
      </volume>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3MXislajt73K
      </pub-id>
      <pub-id pub-id-type="pmid">
       34895305
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8665850
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13063-021-05880-8
      </pub-id>
      <elocation-id>
       911
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR71">
     <label>
      71.
     </label>
     <mixed-citation publication-type="other">
      Office for National Statistics. Internet users UK 2020.
      <ext-link ext-link-type="uri" xlink:href="https://www.ons.gov.uk/businessindustryandtrade/itandinternetindustry/bulletins/internetusers/2020">
       https://www.ons.gov.uk/businessindustryandtrade/itandinternetindustry/bulletins/internetusers/2020
      </ext-link>
      (2020).
     </mixed-citation>
    </ref>
    <ref id="CR72">
     <label>
      72.
     </label>
     <mixed-citation publication-type="other">
      Doody, P. et al.
      <italic>
       Internet access and use among adults aged 50 and over in Ireland: Results from Wave 5 of The Irish Longitudinal Study on Ageing
      </italic>
      .
      <italic>
       The Irish Longitudinal Study on Ageing
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.38018/TildaRe.2020-06">
       https://doi.org/10.38018/TildaRe.2020-06
      </ext-link>
      (2020).
     </mixed-citation>
    </ref>
    <ref id="CR73">
     <label>
      73.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Carter
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Development of a UK Online 24-h Dietary Assessment Tool: myfood24
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2015
      </year>
      <volume>
       7
      </volume>
      <fpage>
       4016
      </fpage>
      <lpage>
       4032
      </lpage>
      <pub-id pub-id-type="pmid">
       26024292
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4488770
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu7064016
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR74">
     <label>
      74.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Threapleton
        </surname>
        <given-names>
         DE
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Usability of myfood24 healthcare and mathematical diet optimisation in clinical populations: a pilot feasibility randomised controlled trial
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2022
      </year>
      <volume>
       14
      </volume>
      <fpage>
       1768
      </fpage>
      <pub-id pub-id-type="pmid">
       35565736
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9101756
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu14091768
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR75">
     <label>
      75.
     </label>
     <mixed-citation publication-type="other">
      Strength exercises—NHS.
      <ext-link ext-link-type="uri" xlink:href="https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/">
       https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/
      </ext-link>
      .
     </mixed-citation>
    </ref>
    <ref id="CR76">
     <label>
      76.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Millor
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <name>
        <surname>
         Lecumberri
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Gómez
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Martínez-Ramírez
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Izquierdo
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       An evaluation of the 30-s chair stand test in older adults: frailty detection based on kinematic parameters from a single inertial unit
      </article-title>
      <source>
       J. Neuroeng. Rehabil.
      </source>
      <year>
       2013
      </year>
      <volume>
       10
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       9
      </lpage>
      <pub-id pub-id-type="doi">
       10.1186/1743-0003-10-86
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR77">
     <label>
      77.
     </label>
     <mixed-citation publication-type="other">
      Dodds, R. M. et al. Prevalence and factors associated with poor performance in the 5‐chair stand test: findings from the Cognitive Function and Ageing Study II and proposed Newcastle protocol for use in the assessment of sarcopenia.
      <italic>
       J. Cachexia Sarcopenia Muscle
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.1002/jcsm.12660">
       https://doi.org/10.1002/jcsm.12660
      </ext-link>
      (2021).
     </mixed-citation>
    </ref>
    <ref id="CR78">
     <label>
      78.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Durbin
        </surname>
        <given-names>
         R
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Fast and accurate short read alignment with Burrows–Wheeler transform
      </article-title>
      <source>
       Bioinformatics
      </source>
      <year>
       2009
      </year>
      <volume>
       25
      </volume>
      <fpage>
       1754
      </fpage>
      <lpage>
       1760
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1MXot1Cjtbo%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       19451168
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2705234
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/bioinformatics/btp324
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR79">
     <label>
      79.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Huerta-Cepas
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Fast genome-wide functional annotation through orthology assignment by eggNOG-Mapper
      </article-title>
      <source>
       Mol. Biol. Evol.
      </source>
      <year>
       2017
      </year>
      <volume>
       34
      </volume>
      <fpage>
       2115
      </fpage>
      <lpage>
       2122
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXhvFaru7vF
      </pub-id>
      <pub-id pub-id-type="pmid">
       28460117
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5850834
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/molbev/msx148
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR80">
     <label>
      80.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kanehisa
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       KEGG: Kyoto Encyclopedia of Genes and Genomes
      </article-title>
      <source>
       Nucleic Acids Res.
      </source>
      <year>
       2000
      </year>
      <volume>
       28
      </volume>
      <fpage>
       27
      </fpage>
      <lpage>
       30
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD3cXhvVGqu74%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10592173
      </pub-id>
      <pub-id pub-id-type="pmcid">
       102409
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/nar/28.1.27
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR81">
     <label>
      81.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kim
        </surname>
        <given-names>
         B-R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Deciphering diversity indices for a better understanding of microbial communities
      </article-title>
      <source>
       J. Microbiol Biotechnol.
      </source>
      <year>
       2017
      </year>
      <volume>
       27
      </volume>
      <fpage>
       2089
      </fpage>
      <lpage>
       2093
      </lpage>
      <pub-id pub-id-type="pmid">
       29032640
      </pub-id>
      <pub-id pub-id-type="doi">
       10.4014/jmb.1709.09027
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR82">
     <label>
      82.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gacesa
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Environmental factors shaping the gut microbiome in a Dutch population
      </article-title>
      <source>
       Nature
      </source>
      <year>
       2022
      </year>
      <volume>
       604
      </volume>
      <fpage>
       732
      </fpage>
      <lpage>
       739
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2022Natur.604..732G
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XpvV2iu7k%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       35418674
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41586-022-04567-7
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR83">
     <label>
      83.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sahu
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Prasuna
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Twin studies: a unique epidemiological tool
      </article-title>
      <source>
       Indian J. Commun. Med.
      </source>
      <year>
       2016
      </year>
      <volume>
       41
      </volume>
      <fpage>
       177
      </fpage>
      <pub-id pub-id-type="doi">
       10.4103/0970-0218.183593
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR84">
     <label>
      84.
     </label>
     <mixed-citation publication-type="other">
      StataCorp. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC. (2019).
     </mixed-citation>
    </ref>
    <ref id="CR85">
     <label>
      85.
     </label>
     <mixed-citation publication-type="other">
      RStudio Team &amp; RStudio: Integrated Development for R.
      <italic>
       RStudio
      </italic>
      . (RStudio, Inc., Boston, MA, 2015).
     </mixed-citation>
    </ref>
    <ref id="CR86">
     <label>
      86.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Black
        </surname>
        <given-names>
         AE
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The sensitivity and specificity of the Goldberg cut-off for EI:BMR for identifying diet reports of poor validity
      </article-title>
      <source>
       Eur. J. Clin. Nutr.
      </source>
      <year>
       2000
      </year>
      <volume>
       54
      </volume>
      <fpage>
       395
      </fpage>
      <lpage>
       404
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BD3c3osVWjuw%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10822286
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/sj.ejcn.1600971
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR87">
     <label>
      87.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Black
        </surname>
        <given-names>
         AE
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Critical evaluation of energy intake using the Goldberg cut-off for energy intake:basal metabolic rate. A practical guide to its calculation, use and limitations
      </article-title>
      <source>
       Int. J. Obes.
      </source>
      <year>
       2000
      </year>
      <volume>
       24
      </volume>
      <fpage>
       1119
      </fpage>
      <lpage>
       1130
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BD3cvosFehsg%3D%3D
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/sj.ijo.0801376
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR88">
     <label>
      88.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <collab>
        Dietary reference values for food energy and nutrients for the United Kingdom.
       </collab>
      </person-group>
      <article-title xml:lang="en">
       Report of the panel on dietary reference values of the committee on medical aspects of food policy
      </article-title>
      <source>
       Rep. Health Soc. Subj. (Lond.)
      </source>
      <year>
       1991
      </year>
      <volume>
       41
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       210
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR89">
     <label>
      89.
     </label>
     <mixed-citation publication-type="other">
      Oksanen, J. et al. vegan: Community Ecology Package [R package version 2.6-4].
      <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=vegan">
       https://cran.r-project.org/package=vegan
      </ext-link>
      (2022).
     </mixed-citation>
    </ref>
    <ref id="CR90">
     <label>
      90.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Holst
        </surname>
        <given-names>
         KK
        </given-names>
       </name>
       <name>
        <surname>
         Scheike
        </surname>
        <given-names>
         TH
        </given-names>
       </name>
       <name>
        <surname>
         Hjelmborg
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The liability threshold model for censored twin data
      </article-title>
      <source>
       Comput. Stat. Data Anal.
      </source>
      <year>
       2016
      </year>
      <volume>
       93
      </volume>
      <fpage>
       324
      </fpage>
      <lpage>
       335
      </lpage>
      <pub-id assigning-authority="American Mathematical Society" pub-id-type="other">
       3406215
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.csda.2015.01.014
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR91">
     <label>
      91.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Scheike
        </surname>
        <given-names>
         TH
        </given-names>
       </name>
       <name>
        <surname>
         Holst
        </surname>
        <given-names>
         KK
        </given-names>
       </name>
       <name>
        <surname>
         Hjelmborg
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Estimating heritability for cause specific mortality based on twin studies
      </article-title>
      <source>
       Lifetime Data Anal.
      </source>
      <year>
       2014
      </year>
      <volume>
       20
      </volume>
      <fpage>
       210
      </fpage>
      <lpage>
       233
      </lpage>
      <pub-id assigning-authority="American Mathematical Society" pub-id-type="other">
       3181012
      </pub-id>
      <pub-id pub-id-type="pmid">
       23378036
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s10985-013-9244-x
      </pub-id>
     </mixed-citation>
    </ref>
   </ref-list>
  </ref-list>
  <app-group>
   <app id="App1" specific-use="web-only">
    <sec id="Sec25">
     <title>
      Uwajibikiano wa taarifa zazifuatazo
     </title>
     <p id="Par73">
      <supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM1_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Supplementary Information
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM2" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM2_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Peer Review File
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM3" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM3_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Reporting Summary
         </p>
        </caption>
       </media>
      </supplementary-material>
     </p>
    </sec>
   </app>
  </app-group>
  <notes notes-type="ESMHint">
   <title/>
   <p>
    The online version contains supplementary material available at
    <ext-link ext-link-type="doi" xlink:href="10.1038/s41467-024-46116-y">
     https://doi.org/10.1038/s41467-024-46116-y
    </ext-link>
    .
   </p>
  </notes>
  <notes notes-type="Misc">
   <p>
    <bold>
     Publisher’s note
    </bold>
    Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
   </p>
  </notes>
 </back>
</article>
